<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002302" GROUP_ID="WOUNDS" ID="018199082314480366" MERGED_FROM="" MODIFIED="2012-11-30 09:17:11 +0000" MODIFIED_BY="Sally Bell-Syer" REVIEW_NO="016" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2012-11-30 09:17:11 +0000" MODIFIED_BY="Sally Bell-Syer">
<TITLE MODIFIED="2009-11-06 12:13:00 +0000" MODIFIED_BY="Elizabeth Royle">Pressure-relieving interventions for treating diabetic foot ulcers</TITLE>
<CONTACT MODIFIED="2012-11-30 09:17:11 +0000" MODIFIED_BY="Sally Bell-Syer"><PERSON ID="FE6C0E9F82E26AA2002F1D7AEDA6DC66" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jane</FIRST_NAME><LAST_NAME>Lewis</LAST_NAME><POSITION>Highly Specialist Podiatrist</POSITION><EMAIL_1>jane.lewis3@wales.nhs.uk</EMAIL_1><EMAIL_2>jane.lewis04@googlemail.com</EMAIL_2><MOBILE_PHONE>07976536985</MOBILE_PHONE><ADDRESS><ORGANISATION>Cardiff and Vale University Health Board</ORGANISATION><CITY>Cardiff</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-11-30 09:17:11 +0000" MODIFIED_BY="Sally Bell-Syer"><PERSON ID="FE6C0E9F82E26AA2002F1D7AEDA6DC66" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jane</FIRST_NAME><LAST_NAME>Lewis</LAST_NAME><POSITION>Highly Specialist Podiatrist</POSITION><EMAIL_1>jane.lewis3@wales.nhs.uk</EMAIL_1><EMAIL_2>jane.lewis04@googlemail.com</EMAIL_2><MOBILE_PHONE>07976536985</MOBILE_PHONE><ADDRESS><ORGANISATION>Cardiff and Vale University Health Board</ORGANISATION><CITY>Cardiff</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="16763" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Allyson</FIRST_NAME><LAST_NAME>Lipp</LAST_NAME><POSITION>Principal Lecturer</POSITION><EMAIL_1>alipp@glam.ac.uk</EMAIL_1><URL>http://www.glam.ac.uk</URL><ADDRESS><DEPARTMENT>Faculty of Health, Sport and Science</DEPARTMENT><ORGANISATION>Department of Care Sciences, University of Glamorgan</ORGANISATION><ADDRESS_1>Glyn Taff Campus</ADDRESS_1><CITY>Pontypridd</CITY><ZIP>CF37 1DL</ZIP><REGION>Rhondda Cynon Taff</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1443 483157</PHONE_1><PHONE_2>+44 1443 483068</PHONE_2><FAX_1>+44 1443 483118</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-11-11 19:25:07 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="2" MONTH="11" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="2" MONTH="11" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="8" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2000"/>
</DATES>
<WHATS_NEW MODIFIED="2012-11-11 19:27:44 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2012-11-11 19:27:39 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>This review includes only trials which consider interventions which aim to treat foot ulcers in people with diabetes and replaces the published review "Pressure relieving interventions for preventing and treating diabetic foot ulcers". The review has been rewritten by two new authors.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-11-11 19:27:44 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>New searches, new trials included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-06-04 11:46:18 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-06-04 11:46:18 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="8" MONTH="5" YEAR="2000"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2011-02-22 17:23:13 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2009-08-15 20:08:43 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-08-15 20:08:43 +0100" MODIFIED_BY="[Empty name]">
<NAME>Cardiff and Vale University Health Board</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Time to undertake the review</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2009-05-06 09:55:32 +0100" MODIFIED_BY="[Empty name]">
<NAME>University of Glamorgan</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Time to undertake the review</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2011-02-22 17:23:13 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2011-02-22 17:23:13 +0000" MODIFIED_BY="[Empty name]">
<NAME>NIHR/Department of Health (England), (Cochrane Wounds Group)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-11-11 19:40:18 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-09-14 09:21:30 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-06-04 11:47:19 +0100" MODIFIED_BY="[Empty name]">Non-removable pressure-relieving interventions help to heal foot ulcers in people with diabetes</TITLE>
<SUMMARY_BODY MODIFIED="2011-09-14 09:21:30 +0100" MODIFIED_BY="[Empty name]">
<P>Foot ulceration is a complication of diabetes and can lead to amputation. Ulcers can occur due, in part, to abnormal pressures on the sole of the foot. The studies included in this review compared non-removable pressure-relieving interventions (foot casts) with other ways of relieving pressure on the ulcer site to improve healing. The comparisons included dressings alone, temporary therapeutic shoes, removable pressure-relieving devices and surgical intervention. The review found that the non-removable interventions were more effective than any of the other external pressure-relieving methods. Non-removable casts used with Achilles tendon lengthening were more successful in one forefoot ulcer study than using a non-removable cast alone.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-11-09 17:59:28 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-04-21 14:23:38 +0100" MODIFIED_BY="Nicky Cullum">
<P>Diabetes-related foot ulceration is a major contributor to morbidity in diabetes. Diabetic foot ulcers are partly a consequence of abnormal foot pressures and pressure relief is a widely used treatment for healing diabetes-related plantar foot ulcers, but the most effective method for healing is unclear.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-10-21 09:13:34 +0100" MODIFIED_BY="[Empty name]">
<P>To determine the effects of pressure-relieving interventions on the healing of foot ulcers in people with diabetes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-11-09 17:59:28 +0000" MODIFIED_BY="[Empty name]">
<P>For this update we searched the Cochrane Wounds Group Specialised Register (searched 2 November 2012); The Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2012, Issue 10); Ovid MEDLINE (1950 to October Week 4 2012); Ovid MEDLINE (In-Process &amp; Other Non-Indexed Citations, October 31, 2012); Ovid EMBASE (1980 to 2012 Week 43); and EBSCO CINAHL (1982 to 1 November 2012). There were no restrictions based on language or publication status.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-06-02 13:31:41 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials evaluating the effects of pressure-relieving interventions on the healing of foot ulcers in people with diabetes.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-11-06 11:14:24 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Data from eligible trials were extracted, and summarised using a data extraction sheet, by two review authors independently.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-09-14 09:20:27 +0100" MODIFIED_BY="[Empty name]">
<P>Fourteen trials (709 participants) met the inclusion criteria for the review. One study compared two different types of non-removable casts with no discernable difference between the groups. Seven studies (366 participants) compared non-removable casts with removable pressure-relieving devices. In five of those studies non-removable casts were associated with a statistically significant increase in the number of ulcers healed compared with the removable device (RR 1.17 95% CI 1.01 to 1.36: P value = 0.04).</P>
<P>Two studies (98 participants) found that significantly more ulcers healed with non-removable casts than with dressings alone. Achilles tendon lengthening combined with a non-removable cast in one study resulted in significantly more healed ulcers at 7 months than non-removable cast alone (RR 2.23; 95% CI 1.32 to 3.76). More ulcers remained healed at two years in this group (RR 3.41; 95% CI 1.42 to 8.18).</P>
<P>Other comparisons included surgical debridement of ulcers; felt fitted to the foot; felted foam dressings and none of these showed a statistically significant treatment effect in favour of the intervention.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-08-24 13:39:18 +0100" MODIFIED_BY="[Empty name]">
<P>Non-removable, pressure-relieving casts are more effective in healing diabetes related plantar foot ulcers than removable casts, or dressings alone. Non-removable devices, when combined with Achilles tendon lengthening were more successful in one forefoot ulcer study than the use of a non-removable cast alone.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-11-11 19:40:18 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-10-24 10:31:26 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2012-09-21 14:32:19 +0100" MODIFIED_BY="[Empty name]">
<P>Diabetes is a serious chronic disease. In 2003, the global prevalence of diabetes was estimated at 194 million (<LINK REF="REF-IDF-2003" TYPE="REFERENCE">IDF 2003</LINK>). This figure is predicted to reach 366 million by 2030 as a consequence of longer life expectancy, sedentary lifestyles and changes in dietary patterns (<LINK REF="REF-Wild-2004" TYPE="REFERENCE">Wild 2004</LINK>). It is likely that this rise in prevalence will be accompanied by a proportional increase in the numbers of people with diabetes-related complications, including problems of the foot (<LINK REF="REF-IDF-2003" TYPE="REFERENCE">IDF 2003</LINK>).</P>
<P>Foot ulceration is a major consequence of diabetes , and is thought to affect 15% of all people with diabetes at some time during their lives (<LINK REF="REF-Frykberg-1998" TYPE="REFERENCE">Frykberg 1998</LINK>; <LINK REF="REF-Reiber-2001" TYPE="REFERENCE">Reiber 2001</LINK>). The pathway to foot ulceration in diabetes involves a complex combination of peripheral vascular disease, nerve disease that causes weakness and numbness (peripheral neuropathy), and often infection (localised or with bone involvement (osteomyelitis)). Decreased pain sensation and muscular spatial awareness due to neuropathy lead to abnormal loading of the foot, which in turn leads to increased pressure on the sole (plantar aspects) of the foot (<LINK REF="REF-Boulton-1996" TYPE="REFERENCE">Boulton 1996</LINK>). These increased foot pressures produce calluses that increase pressure further in the affected areas, and, if left untreated, cause tissue damage. There are both extrinsic and intrinsic pathways to foot ulceration. Extrinsically, peripheral insensitivity may lead to undetected tissue damage and, with the additional presence of peripheral vascular disease, to poor healing (<LINK REF="REF-Boulton-1996" TYPE="REFERENCE">Boulton 1996</LINK>). Other extrinsic factors that can contribute to tissue damage include maceration or rubbing from poorly fitting footwear, and accidental and self-inflicted trauma (e.g. from cutting toe nails) (<LINK REF="REF-Macfarlane-1997" TYPE="REFERENCE">Macfarlane 1997</LINK>). Intrinsic callus formation and the resulting increase in pressure on the plantar aspect of the foot leads to tissue damage.</P>
<P>Peripheral neuropathy (<LINK REF="REF-Abbott-1998" TYPE="REFERENCE">Abbott 1998</LINK>; <LINK REF="REF-Boyko-1999" TYPE="REFERENCE">Boyko 1999</LINK>; <LINK REF="REF-Boulton-2004" TYPE="REFERENCE">Boulton 2004</LINK>), affects approximately 30 to 50% of people with diabetes (<LINK REF="REF-Kumar-1994" TYPE="REFERENCE">Kumar 1994</LINK>). Approximately 45 to 70% of all non-traumatic lower extremity amputations are performed on patients with diabetes (<LINK REF="REF-Boulton-2001" TYPE="REFERENCE">Boulton 2001</LINK>), which makes diabetes the most common underlying cause of these amputations in the US and Europe (<LINK REF="REF-Boulton-2004" TYPE="REFERENCE">Boulton 2004</LINK>; <LINK REF="REF-Jeffcoate-2005" TYPE="REFERENCE">Jeffcoate 2005</LINK>). People with diabetes are 15 to 40 times more likely to undergo an amputation compared to the rest of the population, and this rate is at least 50% higher in men than women (<LINK REF="REF-Frykberg-1998" TYPE="REFERENCE">Frykberg 1998</LINK>; <LINK REF="REF-ADA-2000" TYPE="REFERENCE">ADA 2000</LINK>; <LINK REF="REF-CDCP-2005" TYPE="REFERENCE">CDCP 2005</LINK>). After amputation, foot problems continue to exact a heavy toll on the quality of life of people with diabetes, as the prognosis for the contralateral limb - now at risk - is poor. Survival rates after amputation are generally lower in patients with diabetes than those without it (<LINK REF="REF-Reiber-1995" TYPE="REFERENCE">Reiber 1995</LINK>; <LINK REF="REF-Frykberg-1998" TYPE="REFERENCE">Frykberg 1998</LINK>; <LINK REF="REF-Larsson-1998" TYPE="REFERENCE">Larsson 1998</LINK>). Only 50% of diabetic patients survive for three years after amputation, and only 40% for five years; cardiovascular disease is the major cause of death (<LINK REF="REF-ADA-1996" TYPE="REFERENCE">ADA 1996</LINK>).</P>
<P>Although neuropathic ulceration remains the commonest type of foot ulcer in those with diabetes, recent data suggest that poor blood supply (ischaemia), and, therefore, neuro-ischaemic ulcers (due to poor nerve and blood supply), are on the rise (<LINK REF="REF-Ndip-2009" TYPE="REFERENCE">Ndip 2009</LINK>). Peripheral vascular disease is becoming an increasing problem when considering foot ulcerations, and not just within the diabetic community. Ulcers that occur as a result of poor peripheral circulation usually occur around the borders of the foot, between the toes or on the top (dorsum) of the foot and are predominantly caused by extrinsic factors such as ill-fitting foot wear or trauma (<LINK REF="REF-Boulton-1996" TYPE="REFERENCE">Boulton 1996</LINK>; <LINK REF="REF-Abbott-2002" TYPE="REFERENCE">Abbott 2002</LINK>). This type of ulcer takes a considerable time to heal, due to the poor vascular supply to the foot, and requires appropriate footwear and surgery to improve blood flow to this region in order to initiate the healing process (<LINK REF="REF-Williams-2003" TYPE="REFERENCE">Williams 2003</LINK>). The pressure on these ulcers cannot easily be relieved to promote healing because of their location (<LINK REF="REF-Williams-2003" TYPE="REFERENCE">Williams 2003</LINK>). </P>
<P>The St. Vincent declaration of 1989 set out a number of goals to be achieved relating to diabetes care (<LINK REF="REF-IDF-2003" TYPE="REFERENCE">IDF 2003</LINK>), including a 50% reduction in the number of diabetes-related lower limb amputations within five years. Despite this, the incidence of foot ulceration continues to rise by at least 2% per year. Ulcers often lead to amputations, with and without infection, and have great medical and human, cost implications (<LINK REF="REF-Reiber-1996" TYPE="REFERENCE">Reiber 1996</LINK>; <LINK REF="REF-Abbott-1998" TYPE="REFERENCE">Abbott 1998</LINK>). These include the stigma of having infected ulcers or amputation, and a reduction in quality of life that can often lead to a depressive state.  Patients admitted to hospital with diabetes-related foot ulcers or complications of neuropathy tend to have longer than average hospital stays than for diabetic patients without ulcers (15 to 20 days versus 10 days respectively) (<LINK REF="REF-Reiber-1996" TYPE="REFERENCE">Reiber 1996</LINK>), with the associated human and medical costs being enormous (<LINK REF="REF-Coles-2004" TYPE="REFERENCE">Coles 2004</LINK>).  In western countries, the economic cost of a diabetic foot ulcer is thought to be between US$ 7,000 and US$10,000. This cost may increase to as much as US$ 65,000 per person where healing is complicated and amputation required (<LINK REF="REF-IDF-2003" TYPE="REFERENCE">IDF 2003</LINK>). Conservatively, this is estimated to cost the US health care system $1 billion per year (<LINK REF="REF-Anonymous-2002" TYPE="REFERENCE">Anonymous 2002</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-10-24 10:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>Interventions to treat ulcerations are numerous and varied. The principles of successful treatment are to address three main criteria. Firstly, to ensure a sufficient blood supply to the area; secondly, to treat any underlying infection aggressively; and, finally, to achieve good pressure relief (<LINK REF="REF-Cavanagh-1994" TYPE="REFERENCE">Cavanagh 1994</LINK>). </P>
<P>As plantar pressure relief is the aim, a number of methods are used to redistribute the load on the plantar surface of the foot. These include:</P>
<SUBSECTION>
<HEADING LEVEL="3">Non-removable</HEADING>
<UL>
<LI>
<I>Non-removable pressure-relieving casts</I>: Involves enclosing the entire lower limb in a custom made cast applied by a qualified technician. Often referred to as a &#8216;total contact cast&#8217; (TCC), it involves plaster of Paris or fibreglass and minimal padding, to ensure a close fit against the natural contours of the foot and lower leg. TCC supports the lower leg and redistributes pressures across the foot to relieve pressure on the ulcer. Casts like these that completely enclose the foot and leg are contraindicated where there is an ongoing condition or problem, for example oedema, infection, or peripheral vascular disease. The TCC can be fitted with a heel or 'rocker' to allow the patient to walk. The TCC must be removed to change ulcer dressings.</LI>
<LI>
<I>Instant, non-removable pressure-relieving device</I>: A removable cast walker that has been rendered non-removable by the addition of a fibreglass wrap around the outside of the cast at lower leg level, which prevents it from being easily removed by the patient. Often referred to as a &#8216;instant total contact cast&#8217; (iTCC). This is not a custom made device and does not require a qualified technician for application. As with the TCC it must be removed to change ulcer dressings. Although manufactured as a removable cast walker the studies using this device with fibreglass wrap have labelled it 'non-removable'.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Removable</HEADING>
<UL>
<LI>
<I>Removable cast walkers</I> (RCWs): Produced by various manufacturers, enclose the lower leg and foot and provide pressure redistribution and reduction of mechanical loading to the ulcer site, but are not custom made. RCWs are easily removed for reviews, dressing changes, and patients can walk with them on. Patient compliance may become a problem if the device can be removed too easily. These can be rendered non-removable with the addition of a fibreglass wrap or bandage, still allowing easy removal by the clinician to monitor the lower leg, foot and ulcer.</LI>
<LI>
<I>Therapeutic footwear</I>: Two types; the first is used as an adjunct to treatment and would be a temporary therapeutic shoe or half shoe. The second type is also used as an adjunct to treatment but is a longer term measure, termed bespoke or semi-bespoke footwear with custom-made orthoses. They are designed for the patient individually and can be costly to produce.</LI>
<LI>
<I>Padding</I>: Various materials, such as felt, have been used to temporarily relieve pressure on the foot. They can be applied around acute or chronic wounds, depending on the size, site, type and status of the wound. However, care must be taken not to eliminate pressure in one area merely to increase it on another. Felt padding materials shaped in a particular way can be stuck to skin or footwear to re-distribute pressure away from the ulcer site. They should be replaced regularly for best effect.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Surgical/sharp intervention</HEADING>
<UL>
<LI>
<I>Surgical:</I> Lengthening of the Achilles tendon to reduce pressure under the forefoot has been used in the treatment of diabetes-related forefoot ulceration. </LI>
<LI>
<I>Surgical debridement:</I> Debridement of the ulcer and removal of bone beneath the lesion, with surgical closure, is also classed as a surgical intervention and is used to reduce pressure from diabetes-related plantar ulceration.</LI>
<LI>
<I>Sharp</I>: Callus removal using a scalpel. The formation of callus, a reactive mechanism of the tissues to shearing and normal stress on the skin, is one of the main precursors to ulcer formation. Callus alone is known to increase local pressure, so effective callus removal and prevention are vital in reducing the risk of ulcer formation. Callus can also prevent the wound from healing by increasing pressure when it develops around the wound margins if not removed.</LI>
</UL>
</SUBSECTION>
</INTERVENTION>
<THEORY MODIFIED="2012-10-03 09:54:46 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Non-removable</HEADING>
<UL>
<LI>
<I>Non-removable pressure-relieving casts: </I>The non-removable cast or total contact cast <I>(</I>TCC) are custom made and follow the natural contours of the lower leg and foot. They support the lower leg and redistribute pressures across the bottom of the foot to relieve pressure at the ulcer site. Those who advocate the non-removable total contact cast argue that, although the cast can be restrictive and has contraindications for its use, it does reduce mobility and therefore activity, which initiates a shorter healing time (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>).</LI>
</UL>
<UL>
<LI>
<I>Instant non-removable pressure-relieving device: </I>These devices work in the same way as the removable cast walkers (see below), but they are described as instant total contact casts (iTCC) in the included studies.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Removable</HEADING>
<UL>
<LI>
<I>Removable cast walkers (RCW)</I>: Those advocating the removable walker argue that giving the patient the freedom to remove the cast/walker at night would allow the patient more rest (<LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="REF-Armstrong-2003" TYPE="REFERENCE">Armstrong 2003</LINK>). The walkers are usually lighter than non-removable total contact casts, and can be walked in allowing normal daily activities while relieving pressure to overcome a sedentary lifestyle.</LI>
</UL>
<UL>
<LI>
<I>Therapeutic footwear</I>: The temporary therapeutic shoe or half shoe is a common off-loading device for people with diabetes-related foot ulcers. Therapeutic footwear is designed to promote mobility whilst relieving pressure on the foot ulcer. They are used to reduce the mechanical load on a particular area of the foot or hold a foot in a particular position. Due to the nature of the pressure relief, which is over the heel or forefoot depending on the ulcer site, the patient may need time to adjust to the shoe (<LINK REF="REF-Cantanzariti-1999" TYPE="REFERENCE">Cantanzariti 1999</LINK>).The use of bespoke or semi-bespoke footwear and orthoses allow for a longer term reduction of pressure at a particular site not only promoting the healing of the foot wound but also reducing the risk of re-ulceration at that site. They work on the principle of pressure redistribution and reduction of mechanical loading.</LI>
</UL>
<UL>
<LI>
<I>Padding</I>: Appropriately shaped padding materials can be used to relieve pressure over plantar ulcers by redistributing the load away from the ulcer site. The padding can be adhered directly to the skin (thus preventing slippage), or can be adhered to the insole of footwear, which allows ulcer dressings to be left in place on the foot, and so makes dressing changes easier. Padding needs to be replaced regularly, as many materials 'bottom out' after short periods of time due to compression from the downward pressure of body weight combined with the upward ground-reaction forces (<LINK REF="REF-Needleman-1997" TYPE="REFERENCE">Needleman 1997</LINK>).</LI>
</UL>
<UL>
<LI>
<I>Dressings</I>: When used alone dressings do not provide any pressure relief.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Surgical/sharp intervention</HEADING>
<UL>
<LI>
<I>Surgical:</I> Tendons can become shorter due to motor-neuropathy. Shortening of the Achilles tendon causes plantar flexion, thus reducing the ability of the heel to maintain ground contact (equinus). This increases pressure under the metatarsal heads. Surgical intervention to lengthen the Achilles tendon allows the heel to resume its normal position, in line with the forefoot. This surgical intervention is usually combined with a total contact cast whilst healing is taking place (<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>).</LI>
</UL>
<UL>
<LI>
<I>Surgical debridement</I>: Those ulcers that penetrate to the bone are usually infected, and often the bone becomes infected too. Infected bone can become brittle, and fragments can break away. These prominent pieces of bone can cause increases in pressure and prevent ulcers from healing. Surgical debridement of grossly infected ulcers, or removal of a fragment or piece of infected bone with surgical closure, can, in some cases, promote ulcer healing (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="REF-Giurini-1995" TYPE="REFERENCE">Giurini 1995</LINK>; <LINK REF="REF-Rosenblum-1994" TYPE="REFERENCE">Rosenblum 1994</LINK>).</LI>
</UL>
<UL>
<LI>
<I>Sharp debridement: </I>By reducing the callus surrounding the ulcer with a scalpel, pressure is reduced, and the likelihood of the callus preventing the ulcer from healing, may be reduced. Callus removal must be done regularly, and usually cushioning or orthoses would be considered as a longer-term solution (<LINK REF="REF-Young-1991" TYPE="REFERENCE">Young 1991</LINK>).</LI>
</UL>
</SUBSECTION>
</THEORY>
<IMPORTANCE MODIFIED="2012-10-03 09:55:13 +0100" MODIFIED_BY="[Empty name]">
<P>Various plantar pressure-relieving methods are used in practice, however it is not clear which method is the most effective.</P>
<P>A Cochrane review completed in 2000 considered pressure-relieving devices to prevent and treat foot ulcers in people with diabetes (<LINK REF="REF-Spencer-2000" TYPE="REFERENCE">Spencer 2000</LINK>). This review has been updated and will be republished as two reviews that consider prevention and treatment separately. Another (non-Cochrane) systematic review considered studies of footwear and pressure-relieving interventions to prevent and heal foot ulcers, however, this review was not restricted to randomised controlled trials (RCTs), but included studies with many designs (<LINK REF="REF-Bus-2008" TYPE="REFERENCE">Bus 2008</LINK>).</P>
<P>This review will seek to reduce uncertainty by summarising the available research evidence regarding the effects of pressure-relieving methods on the healing of diabetes-related foot ulcers.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-10-24 10:31:28 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of pressure-relieving interventions on the healing of diabetes-related foot ulcers.</P>
<P>Where primary research allows, a distinction will be made between ulceration associated with neuropathy, ulceration associated with ischaemia (poor blood supply), and ulceration associated with both neuropathy (poor nerve supply) and ischaemia (neuro-ischaemic ulcers).<BR/>
</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-11-11 19:34:47 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-11-11 19:34:47 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2010-10-21 09:13:34 +0100" MODIFIED_BY="[Empty name]">
<P>All published and unpublished randomised controlled trials (RCTs) that compare a pressure-relieving intervention with either another pressure-relieving intervention, or treatment as usual (for example, traditional dressing, advice to rest) for the management of diabetes-related foot ulcers. Quasi-randomised trials were not eligible (e.g. trials that allocate treatment by sequential record number, sequential admitting number or by day of the week). </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-10-21 09:13:34 +0100" MODIFIED_BY="[Empty name]">
<P>Adults and children with type 1 or type 2 diabetes mellitus with foot ulcers of any severity, in any setting.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-02-03 07:20:53 +0000" MODIFIED_BY="[Empty name]">
<P>Studies reporting the following comparisons of pressure-relieving interventions were eligible for inclusion:</P>
<OL>
<LI>An external pressure-relieving intervention compared with another external pressure-relieving intervention, or no pressure-relieving intervention</LI>
<LI>A surgical pressure-relieving intervention with, or without, an external pressure-relieving intervention compared with another external pressure-relieving intervention, or no pressure-relieving intervention.</LI>
</OL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-11-11 19:34:47 +0000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2010-10-21 09:47:23 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Time to complete healing or proportion of ulcer(s) completely healed in trial time.</LI>
<LI>Healing rates.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2012-11-11 19:34:47 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Complications e.g. discomfort, skin damage, pain, clinical infection and amputation.</LI>
<LI>Patient satisfaction and quality of life.</LI>
<LI>Economic analysis.</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-11-09 17:58:51 +0000" MODIFIED_BY="[Empty name]">
<P>The search methods section of the original version of the review can be found in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<ELECTRONIC_SEARCHES MODIFIED="2012-11-09 17:58:51 +0000" MODIFIED_BY="[Empty name]">
<P>For this update we searched the following electronic databases:</P>
<UL>
<LI>The Cochrane Wounds Group Specialised Register (searched 2 November 2012);</LI>
<LI>The Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2012, Issue 10);</LI>
<LI>Ovid MEDLINE (1950 to October Week 4 2012);</LI>
<LI>Ovid MEDLINE (In-Process &amp; Other Non-Indexed Citations, October 31, 2012);</LI>
<LI>Ovid EMBASE (1980 to 2012 Week 43);</LI>
<LI>EBSCO CINAHL (1982 to 1 November 2012).</LI>
</UL>
<P>The following search strategy was used in The Cochrane Central Register of Controlled Trials (CENTRAL):<BR/>
<BR/>#1 pressure NEXT relie*<BR/>#2 pressure NEXT reduc*<BR/>#3 pressure NEXT (distribut* or redistribut*)<BR/>#4 alternat* NEXT pressure<BR/>#5 "constant pressure"<BR/>#6 MeSH descriptor Bed Rest explode all trees<BR/>#7 "bed rest"<BR/>#8 MeSH descriptor Bony Callus explode all trees<BR/>#9 callus<BR/>#10 hosiery<BR/>#11 stocking*<BR/>#12 MeSH descriptor Shoes explode all trees<BR/>#13 shoe* or boot* or footwear<BR/>#14 MeSH descriptor Orthotic Devices explode all trees<BR/>#15 orthoses or orthosis<BR/>#16 orthotic*<BR/>#17 insole*<BR/>#18 foot NEXT insert*<BR/>#19 cushion*<BR/>#20 heel NEXT elevat*<BR/>#21 elevat* NEXT device*<BR/>#22 foot NEXT elevat*<BR/>#23 foot NEXT lift*<BR/>#24 cast or casts or casting<BR/>#25 aircast* or scotchcast* or neofract<BR/>#26 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25)<BR/>#27 MeSH descriptor Diabetic Foot explode all trees<BR/>#28 MeSH descriptor Foot Ulcer explode all trees<BR/>#29 diabet* NEAR/3 ulcer*<BR/>#30 diabet* NEAR/3 (foot or feet)<BR/>#31 (#27 OR #28 OR #29 OR #30)<BR/>#32 (#26 AND #31)</P>
<P>The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>, <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>, respectively. We combined the Ovid MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision) (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). The EMBASE and CINAHL searches were combined with the trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<LINK REF="REF-SIGN-2011" TYPE="REFERENCE">SIGN 2011</LINK>). No date or language restrictions were applied.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-10-05 08:51:32 +0100" MODIFIED_BY="[Empty name]">
<P>Reference lists for all retrieved studies were searched for additional studies. Manufacturers (Benefoot UK, Aircast Walker USA, 3M Healthcare UK) and professional organisations (Society of Chiropodists and Podiatrists, UK) were contacted in order to obtain any ongoing or unpublished data.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-10-03 09:55:43 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2011-06-02 09:52:03 +0100" MODIFIED_BY="[Empty name]">
<P>Both review authors independently assessed the titles and abstracts of the references identified by the search strategy. Full reports of all potentially relevant trials were assessed for eligibility based on the review's inclusion criteria. The reference sections of retrieved studies were screened to identify any further studies, which were then retrieved. Differences of opinion were settled through discussion to achieve consensus or by referral to the editorial base of the Wounds Group.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-10-03 09:55:43 +0100" MODIFIED_BY="[Empty name]">
<P>Both review authors independently used a piloted data extraction sheet to extract the following data from each study:</P>
<OL>
<LI>Type of study.</LI>
<LI>Type of intervention.</LI>
<LI>Details of comparison intervention.</LI>
<LI>Country where study conducted.</LI>
<LI>Study setting.</LI>
<LI>Baseline characteristics of participants and ulcers.</LI>
<LI>Number of participants.</LI>
<LI>Inclusion and exclusion criteria.</LI>
<LI>Criteria for healing (as defined by the author). Outcome data will be recorded at all time points as reported by the trial authors.</LI>
<LI>Complications associated with infection.</LI>
<LI>Duration of follow-up.</LI>
<LI>Trials sponsored by manufacturers of pressure-relieving devices.</LI>
<LI>Economic analysis.</LI>
<LI>Patient satisfaction and quality of life.</LI>
</OL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-09-21 14:32:54 +0100" MODIFIED_BY="[Empty name]">
<P>The two review authors independently assessed each included study using the Cochrane Collaboration tool for assessing risk of bias and study quality (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). This tool addresses six specific domains, namely, sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other issues (e.g. extreme baseline imbalance, timing of outcome assessment and trial sponsorship - see <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK> for details of criteria on which the judgement is based). The review authors independently completed a risk of bias table for each eligible study, and discussed any disagreements between them until consensus was achieved. Where information was not available in the published study report, the review authors contacted the study authors in order to obtain information to allow a complete assessment.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-06-02 13:38:56 +0100" MODIFIED_BY="[Empty name]">
<P>Data were entered into, and analysed using, Review Manager 5 (RevMan) software.  Results were presented with 95% confidence intervals (CI).  Estimates for dichotomous outcomes (e.g. ulcers healed - yes or no) were reported as relative risk (RR). We intended to convert continuous data (e.g. total area healed) to the standardised mean difference (SMD) (or mean difference (MD)) when possible, and to calculate overall effect size (with 95% CI). Outcomes were reported at the 12 week endpoint if possible otherwise the endpoints were used as stated by the study authors. Time to complete wound healing is a type of time-to-event data and the most appropriate way of summarizing time-to-event data is to use methods of survival analysis and express the intervention effect as a hazard ratio. Where studies reported time to healing but had not employed survival methods we only present the results narratively, except where it was clearly stated that all participants had healed (in which case there is no need to account for censoring and the healing time can be treated as continuous data). </P>
</EFFECT_MEASURES>
<DATA_SYNTHESIS MODIFIED="2012-09-22 20:31:48 +0100" MODIFIED_BY="[Empty name]">
<P>We included all eligible trials in the initial analysis, and planned to carry out sensitivity analyses to evaluate the effect of trial quality. This was to be done by excluding those trials with inadequate allocation concealment and uncertain or unblinded patients, care providers or outcome assessors, which were most susceptible to bias, based on our risk of bias assessment.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-06-02 09:52:27 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to assess the sensitivity of the results to exclusion of studies at high risk of bias. We planned to undertake a subgroup analysis for the effects of the intervention in specific patient groups (for example type 1 and type 2 diabetes) and to identify possible sources of heterogeneity. Subgroup analysis was planned for a comparison of trials with and without commercial sponsorship to see if sponsorship influenced findings. We planned to test for heterogeneity using the Chi<SUP>2</SUP> statistic, with a P value of 0.10 used as the cut-off value to determine statistical significance.  In addition, the degree of heterogeneity was investigated by calculating the l<SUP>2 </SUP>statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).  A meta-analysis was planned using a fixed-effect model if I<SUP>2</SUP> was less than 30%, a random-effects model if I<SUP>2</SUP> was greater than 30% but less than 60%, but no meta-analysis was planned if I<SUP>2</SUP> was greater than 60%. We planned to conduct a narrative review of eligible studies where statistical synthesis of data from more than one study was not possible or considered inappropriate.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-11-11 19:40:18 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-11-11 19:39:31 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-11-11 19:39:31 +0000" MODIFIED_BY="[Empty name]">
<P>The search identified 270 articles; 40 of these were considered potentially relevant after the titles had been screened. Full text copies were retrieved and reviewed independently against the inclusion criteria by two review authors. Nineteen studies were subsequently excluded (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). Two references were retrieved through scanning reference lists (<LINK REF="STD-Colagiuri-1995" TYPE="STUDY">Colagiuri 1995</LINK>; <LINK REF="STD-Ha-Van-2003" TYPE="STUDY">Ha Van 2003</LINK>). No references were retrieved through contact with manufacturers or professional organisations. One study is ongoing (<LINK REF="STD-Agas-2006" TYPE="STUDY">Agas 2006</LINK>). Two studies are awaiting assessment pending full text retrieval (<LINK REF="STD-Gutekunst-2011" TYPE="STUDY">Gutekunst 2011</LINK>; <LINK REF="STD-Vallini-2012" TYPE="STUDY">Vallini 2012</LINK>).</P>
<P>Six authors (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>) responded to requests for additional unpublished information. One author (<LINK REF="STD-Agas-2006" TYPE="STUDY">Agas 2006</LINK>) confirmed the study was ongoing. Six trial reports were duplicate publications of included studies (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK> (two additional reports); <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK> (two additional reports); <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK> (one additional report) and <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> (one additional report).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-10-24 10:31:44 +0100" MODIFIED_BY="[Empty name]">
<P>Fourteen RCTs (i.e. 20 citations) with 709 participants met the inclusion criteria for the review (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>) (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). All studies were small, trial sizes ranged from 38 to 75 participants.</P>
<P>All but one study (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>), were single centre trials. Five were based in the US (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>), five in Italy (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>), and one each in Germany (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>), the Netherlands (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>), Australia (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>) and India (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>). A power calculation was reported in two trials (<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>); as the effect size was greater than anticipated for all outcome measures in <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>, this trial was terminated prematurely. Data from two trials were reported in four other publications (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>), the authors were contacted to ensure that the correct trial report was identified as the primary source.</P>
<P>All studies enrolled participants with diabetes-related neuropathic, plantar foot ulcers. These were defined as meeting the Wagner Grade I or II criteria (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>), University of Texas Wound Classification (TWC) A1 (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>), A1 or A2 (<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>) or B1 (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>). Further assessments included the insensitivity to the Semmes-Weinstein monofilament sensitivity test 10g (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>), or the vibration perception threshold test (less than 25 volts) (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>), or both (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>).  All patients were assessed for peripheral vascular disease (PVD), and were excluded if it was present. </P>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>In the twelve studies that reported age (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>), the mean age of the participants was between 50 years and 66 years. Two studies did not report participant age (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>). All trials enrolled both men and women with diabetes. Five trials distinguished between Type 1 and Type 2 diabetes (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>), and three between non-insulin dependent diabetes mellitus and insulin dependent diabetes mellitus (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>Nine of the fourteen trials compared a type of non-removable cast with another form of pressure-relieving device (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>). One trial (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>) comprised three groups and compared a non-removable cast, a removable cast and a temporary therapeutic shoe. One trial compared one type of non-removable cast with another non-removable cast (<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>).</P>
<P>One trial evaluated a surgical approach (Achilles tendon lengthening) in addition to a non-removable cast (<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>). Two trials considered felt fitted to the foot compared with either a therapeutic shoe (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>) or felt adhered to the shoe (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>). One trial compared surgical debridement of the ulcer, antiseptic dressings and a therapeutic shoe with saline dressings and a therapeutic shoe (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Primary outcome</HEADING>
<P>Nine of the fourteen studies defined healing as complete re-epithelization, (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>) or scar formation (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>). Thirteen studies reported the number of ulcers healed and one study reported the proportion of ulcers healed only (as %) with no raw data (<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>). Reduction in ulcer size over the study period was reported in three studies (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>).</P>
<P>Time to healing was reported in all studies; frequently wrongly analysed as continuous rather than survival data. Analysing time to healing as continuous data is wrong because using this approach, the time to healing can only be analysed for those participants who experienced the event (i.e. healed) and censored participants must be excluded which almost certainly introduces bias. In such instances we present the results in narrative form only, however in the cases where all ulcers healed (and censoring is not an issue) we analysed and presented the continuous data. Where Kaplan-Meier life table analysis was performed but hazard ratios were not reported, we have only reported the data narratively and not used it in pooling or graphical plots.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<OL>
<LI>Complications were reported in the form of infection including maceration and osteomyelitis (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>), further ulceration (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>), skin maceration (<LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>) and no infective complications associated with pressure-relieving device (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>). Amputation was reported in seven studies (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>).</LI>
<LI>Patient satisfaction was reported in two studies (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>) and quality of life was not reported in any study.</LI>
<LI>Economic evaluation in the form of cost was reported in three studies (<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>).</LI>
</OL>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2011-02-03 15:54:28 +0000" MODIFIED_BY="[Empty name]">
<P>Nineteen studies were excluded from the review. Fifteen because they were not RCTs (<LINK REF="STD-Borssen-1989" TYPE="STUDY">Borssen 1989</LINK>; <LINK REF="STD-Samanta-1989" TYPE="STUDY">Samanta 1989</LINK>; <LINK REF="STD-Black-1990" TYPE="STUDY">Black 1990</LINK>; <LINK REF="STD-Helm-1991" TYPE="STUDY">Helm 1991</LINK>; <LINK REF="STD-Guzman-1994" TYPE="STUDY">Guzman 1994</LINK>; <LINK REF="STD-Mueller-1995" TYPE="STUDY">Mueller 1995</LINK>; <LINK REF="STD-Lavery-1996" TYPE="STUDY">Lavery 1996</LINK>; <LINK REF="STD-Lin-1996" TYPE="STUDY">Lin 1996</LINK>; <LINK REF="STD-Lavery-1997" TYPE="STUDY">Lavery 1997</LINK>; <LINK REF="STD-Armstrong-1998" TYPE="STUDY">Armstrong 1998</LINK>; <LINK REF="STD-Hartsell-2001" TYPE="STUDY">Hartsell 2001</LINK>; <LINK REF="STD-Birke-2002" TYPE="STUDY">Birke 2002</LINK>; <LINK REF="STD-Ha-Van-2003" TYPE="STUDY">Ha Van 2003</LINK>; <LINK REF="STD-Matricali-2003" TYPE="STUDY">Matricali 2003</LINK>; <LINK REF="STD-Nabuurs_x002d_Franssen-2005" TYPE="STUDY">Nabuurs-Franssen 2005</LINK>). The remaining four trials were excluded either because they focused on ulcer prevention (<LINK REF="STD-Colagiuri-1995" TYPE="STUDY">Colagiuri 1995</LINK>; <LINK REF="STD-Uccioli-1995" TYPE="STUDY">Uccioli 1995</LINK>), or because the outcome data could not be extracted (<LINK REF="STD-Tyrrell-1998" TYPE="STUDY">Tyrrell 1998</LINK>; <LINK REF="STD-Salsich-2005" TYPE="STUDY">Salsich 2005</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-10-24 10:31:54 +0100" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> for the results of the risk of bias assessments. Only three of the fourteen studies were assessed as being of low risk of bias (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>), i.e. having adequate allocation concealment, sequence generation and blinded outcome assessment.</P>
<ALLOCATION MODIFIED="2012-10-24 10:31:47 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Generation of randomisation sequence</HEADING>
<P>In all trials, authors stated that participants were randomly allocated to an intervention. Five studies used a computerised randomisation schedule (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>), four used a table of random numbers (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>), one used a randomised list in blocks of ten (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>), one used 'codebreak' envelopes (personal correspondence)(<LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>), one drew lots in unsealed envelopes (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>), one tossed a coin (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>), and the method of randomisation was not stated in one study(<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Concealment of treatment allocation was assessed as adequate for eight studies. In three studies allocation of treatment was carried out by an independent coordinator (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>) in three studies selection of sealed envelopes was used (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>), and two studies took the &#8216;next assignment from the concealed list&#8217; (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>). Despite contact with the authors, it is still unclear what method of concealment of treatment allocation was used in six trials (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>).</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2012-09-21 14:35:33 +0100" MODIFIED_BY="[Empty name]">
<P>Blinding of the care provider and outcome assessor was only described in three studies<B> </B>(<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>). In one study the outcome assessor was blinded, but the care-provider was not (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>). <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> blinded the care provider but not the outcome assessor. In the remaining nine studies, blinding was not referred to (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-10-24 10:31:54 +0100" MODIFIED_BY="[Empty name]">
<P>Three studies reported an intention-to-treat analysis, however methods used could not be confirmed (<LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>). One study stated that an ITT analysis was performed only for one participant who crossed over to the alternative treatment group, but data on those who dropped out were not included therefore this was judged not to be an adequate ITT analysis (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>). Four studies stated that intention-to-treat analysis was not performed (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>), and five studies did not state an intention-to-treat was performed (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>).</P>
<P>Two studies reported no dropouts (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>;). Three studies did not report dropouts (<LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>). Nine studies reported and accounted for all dropouts (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>). Reasons for dropping out were variously given as death during the treatment phase (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>; <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>); serious infection requiring antibiotic therapy and surgical debridement (<LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>); forefoot amputation (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>); discomfort of device <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; failure to attend appointments <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; clinician withdrawal of a participant in order to change the pressure-relieving intervention; compliance failure; erroneous removal of pressure-relieving intervention by general practitioner (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>); and self-withdrawal (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>). In one study (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>), 75 patients were enrolled but 12 failed to complete the study due to discomfort (seven participants: four non-removable cast, three removable device), instability (one participant; removable device), or failure to return for appointments (four participants: two non-removable cast, two removable device). In one study no reason was given for three patients being lost to follow-up (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>). In one study six were lost to follow up and one patient was found to have had osteomyelitis before study entry (<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-06-02 09:53:33 +0100" MODIFIED_BY="[Empty name]">
<P>Selective outcome reporting was not fully assessed as we did not review trial protocols. From the published studies there was no evidence of selective outcome reporting as studies reported on the outcomes specified in the trial reports. </P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-10-24 08:27:55 +0100" MODIFIED_BY="[Empty name]">
<P>There were some baseline imbalances in three studies which may have affected outcomes (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>). These included ulcer duration and HbA1c (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>). </P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-11-11 19:40:18 +0000" MODIFIED_BY="[Empty name]">
<P>This review includes outcome data from fourteen trials with a total of 709 participants. Five comparisons were evaluated:</P>
<UL>
<LI>Non-removable pressure relieving cast compared with another non-removable pressure relieving device (<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK>).</LI>
<LI>Removable pressure relieving device compared with another removable pressure-relieving device (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>; <LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>).</LI>
<LI>Non-removable, pressure relieving cast compared with removable pressure-relieving device (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>).</LI>
<LI>Non-removable, pressure relieving device compared with no pressure relief (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>; <LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>).</LI>
<LI>Surgical interventions (<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>).</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: Non-removable pressure relieving cast compared with another non-removable pressure relieving device</HEADING>
<P>One trial with 41 participants addressed this comparison. <LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK> compared a standard non-removable total contact cast (TCC) with a removable cast walker which was rendered non-removable by wrapping it with a single layer of fibreglass casting material to make an instant total contact cast (iTCC). The trial had a moderate risk of bias as allocation concealment and blinding of care provider and outcome assessor were unclear.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>This study reports the proportion of people with completely healed ulcers as a percentage but does not provide raw numbers; furthermore six participants were lost to follow up and one was withdrawn. The authors report (what appears to be a) complete case analysis stating that 74% of people in the standard total contact cast group completely healed compared with 80% in the customised total contact cast group (no statistically significant difference was reported by the study author (P value = 0.65)). These data appear to refer to an analysis which assumes those lost to follow up did not heal. The authors then report an analysis excluding those lost to follow up stating that 93% of those in the standard TCC group healed compared with 94% in the customised TCC group which was also not statistically significant (P value = 0.97).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>Time to healing is reported in the trial in a way that is difficult to interpret and therefore the reported data cannot be analysed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>
<LINK REF="STD-Katz-2005" TYPE="STUDY">Katz 2005</LINK> reported risk of skin maceration with TCC vs iTCC (RR 1.23; 95% CI 0.50 to 3.02)(<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) and toe amputation with TCC vs iTCC (RR 1.05; 95% CI 0.07 to 15.68)(<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). There was no evidence of statistically significant differences for these outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Economic analysis</HEADING>
<P>The cost of a course of treatment was reported including the number of times the cast required changing, cost of materials and the median salary of a cast technician. The instant non-removable cast cost $158.47 (USD) and the non-removable cast cost $210.67 for the full course of treatment.</P>
<P>The outcomes of patient satisfaction and quality of life were not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2: Removable pressure relieving device compared with another removable pressure-relieving device</HEADING>
<P>In this analysis three trials with 143 participants compared removable pressure relieving devices with other removable pressure-relieving devices. Pooling of the studies was not possible as the interventions differed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Removable cast walker compared with removable half shoe</HEADING>
<P>This analysis included one trial with 50 participants (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>) which compared a removable cast walker (Aircast Diabetic Walker) with a temporary therapeutic half shoe. The trial had a moderate risk of bias as allocation concealment was unclear.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>There was no statistically significant difference between removable cast walkers and temporary therapeutic shoes in the number of neuropathic, plantar foot ulcers healed (P value = 0.78)(RR of healing with RCW compared with shoe was 0.93, 95% CI 0.56 to 1.55) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>.1).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>Reported time to healing, using a Kaplan-Meier life-table analysis (log-rank test), in the removable cast walker group was six weeks compared with nine weeks in the temporary therapeutic shoe group. Significant difference in cumulative wound survival was noted by the study authors at 12 weeks between patients treated with a half shoe and RCW (P value 0.033).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Patient satisfaction</HEADING>
<P>Three people in the removable device group discontinued the study because of discomfort and one person in the removable half shoe discontinued because of instability. No patients were included in the analysis.</P>
<P>The outcomes of complications and economic analysis were not considered by this study.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Felt fitted to foot compared with felt fitted to temporary therapeutic footwear</HEADING>
<P>This analysis included one trial with 38 participants (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>). This trial compared felt padding adhered directly to the foot with felt padding adhered to a temporary therapeutic shoe. The risk of bias in this trial was high due to lack of information on sequence generation and lack of blinding of patients and outcomes assessment.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>The trial reported diabetes-related neuropathic plantar foot ulcer healing at 14 weeks. There was no statistically significant difference between the number of ulcers healed in either group (P value = 0.09) (RR of healing with foot felt compared with footwear felt was 0.68, 95% CI 0.43 to 1.06)(<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>.2).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>Time to healing was presented as a Kaplan-Meier life-table analysis (log-rank test). This showed no difference in time to healing in that according to the study authors fifty percent of wounds healed in both groups at about eight weeks (<LINK REF="STD-Nube-2006" TYPE="STUDY">Nube 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>One case of skin maceration was reported in the felt fitted to the foot group. Two cases of amputation of the hallux were reported, but the treatment group was not specified in either case.</P>
<P>The outcomes of economic analysis cost and patient satisfaction and quality of life were not considered by this study.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Felted foam dressing compared with temporary therapeutic footwear</HEADING>
<P>This analysis included one trial with 61 participants (<LINK REF="STD-Zimny-2002" TYPE="STUDY">Zimny 2002</LINK>). The study compared felted foam adhered to the foot with a temporary therapeutic half-shoe that transferred weight to the heel. This study was at moderate risk of bias as sequence generation and blinding of care provider were unclear and there was no blinding of patients.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>The trial reported diabetes-related neuropathic plantar foot ulcer healing at 10 weeks. There was no statistically significant difference between the number of ulcers healed in either group (P value = 0.26)(RR of healing with foam dressing compared with footwear was 1.35 95% CI 0.80 to 2.28)(<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>.3).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>Mean time to healing was reported by study authors as 79.6 days (95% CI 75 to 84 days) in the felted foam dressing group and 83.2 days (95% CI 77 to 90 days) in the temporary therapeutic shoe group using a Kaplan-Meier life-table analysis (log-rank test) although the difference was not statistically significant (P value 0.61).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>Six infections were reported in the felted foam group and six in the temporary therapeutic shoe group.</P>
<P>The outcomes of economic analysis, patient satisfaction and quality of life were not considered by this study.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3: Non-removable pressure relieving device compared with removable pressure-relieving device</HEADING>
<P>This comparison of seven trials with a total of 366 participants compared non-removable pressure relieving devices with removable pressure-relieving devices.</P>
<P>Five trials with 230 participants were analysed comparing a non-removable total contact device with a removable device (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>). Two trials compared total contact casts with Aircast Diabetic Walker (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>) and Optima Diab Walker (<LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>). One trial compared an instant total contact cast with an Active Offloading Walker (<LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>). One trial compared a non-removable cast with a Stabil-D Walker (<LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>) and one trial compared a non-removable cast with an Aircast Pneumatic Walker (<LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>). All five studies were overall at moderate risk of bias. All studies were at low risk of bias for sequence generation but three studies were unclear on allocation of concealment (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>). All studies were at high risk or unclear for blinding of patients.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>All five trials reported the number of foot ulcers healed at 12 weeks. A meta-analysis was performed using a fixed-effect model as heterogeneity was absent at 0%. Significantly more ulcers healed in the non-removable device group (RR 1.17 95% CI 1.01 to 1.36)(<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.1).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>
<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK> reported time to healing using a Kaplan-Meier life-table analysis (log-rank test) where the median time to healing was 4 weeks for the non-removable cast group and six weeks for the removable walker group. <LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK> reported time to healing using a Kaplan-Meier life-table analysis (log-rank test) where the median time to healing was 6 weeks for the instant non-removable pressure relieving device and 10 weeks for the removable cast walker. <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK> reported time to healing using a Kaplan-Meier life-table analysis (log-rank test) where the median time to healing was 4 weeks in the non-removable cast group and 6 weeks in the removable cast walker group. This study also reported that all participants healed and therefore although hazard ratios were not reported we have presented the data in <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>. There was no statistically significant difference between groups (P= 0.87)(MD -1.40 days; 95% CI -18.46 to 15.66). <LINK REF="STD-Caravaggi-2007" TYPE="STUDY">Caravaggi 2007</LINK> reported time to healing using a Kaplan-Meier life-table analysis (log-rank test) where the median time to healing was 48 days for the non-removable cast group and 71 days for the removable walker group. <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK> reported the mean time to healing as 35.3 days in the non-removable cast group and 39.7 days in the removable walker group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>Skin maceration outcomes, reported in three studies (<LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK>; <LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>; <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK>), were pooled in a meta-analysis which showed no significant difference in the risk of skin maceration between devices (P= 0.27) (RR for maceration with non-removable compared with removable device, was 1.38 95% CI 0.78 to 2.44) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.2).</P>
<P>The outcomes of patient satisfaction and quality of life were not considered by these studies. Costs were reported in one study (<LINK REF="STD-Faglia-2010" TYPE="STUDY">Faglia 2010</LINK>).The removable walker cost 150 euros, the non-removable device, 147 euros. The total costs over the study period were 3,300 euros in the removable group and 6,688 euros for the non-removable group.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Non-removable cast compared with temporary therapeutic footwear</HEADING>
<P>The subgroup comparing a non-removable device with temporary therapeutic footwear included three trials with a total of 131 participants (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>). <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK> and <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK> compared a total contact device (non-removable) with a temporary therapeutic shoe, <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK> compared a fibreglass total contact cast (non removable) with an Aircast Pneumatic Walker (removable). Outcomes were reported at different time points from 30 days (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>), 12 weeks (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>) and at 16 weeks (<LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>).</P>
<P>All three studies were overall at moderate risk of bias. All had adequate generation of the randomisation sequence but only two adequately concealed the allocation to treatment groups (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>) and only two blinded the care provider and outcome assessor (<LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>Three trials reported the number of foot ulcers healed at 30 days, 12 weeks and 16 weeks respectively (<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>; <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>; <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK>). Each trial reported that more ulcers healed in the non-removable pressure-relieving device group than in the removable device group, <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK> (RR 1.24 95% CI 0.75 to 2.04), <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK> (RR 0.87 95% CI 0.33 to 2.27). In one study, <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>, significantly more ulcers healed in the non-removable device group (RR 2.40 95% CI 1.01 to 5.73)(<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.3). A meta-analysis was undertaken using a fixed-effect model as I<SUP>2</SUP> as heterogeneity was less than 30% (25%) (RR 1.41 95% CI 0.93 to 2.14), there was no statistically significant difference between the group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>
<LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK> did not report time to healing. In <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK> and <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK>, time to healing was reported but with no hazard ratios. in a way that is difficult to interpret and therefore the reported data cannot be analysed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>
<LINK REF="STD-Armstrong-2005" TYPE="STUDY">Armstrong 2005</LINK> and <LINK REF="STD-Piaggesi-2007" TYPE="STUDY">Piaggesi 2007</LINK> reported skin maceration but these could not be pooled as the time to healing varied considerably. The longer an ulcer is open the more vulnerable it is to further complications. No complications were reported in <LINK REF="STD-Armstrong-2001" TYPE="STUDY">Armstrong 2001</LINK> and <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>. One amputation was reported in <LINK REF="STD-Van-de-Weg-2008" TYPE="STUDY">Van de Weg 2008</LINK> in the non-removable group, but not its location.</P>
<P>The outcomes of economic analysis, patient satisfaction and quality of life were not considered by these studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 4: Non-removable pressure relieving device compared with no pressure relief</HEADING>
<P>The subgroup comparing non-removable pressure relieving cast with dressing included two trials with a total of 98 participants. <LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK> compared a total contact cast (TCC)(non-removable) with a traditional saline dressing and accommodative footwear. <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK> also compared total contact casts (non-removable) with a sterile gauze dressing and mupirocin ointment. <LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK> was at low risk of bias for reporting adequate sequence generation and allocation concealment and moderate risk of bias with no blinded outcome assessment. <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK> was at moderate risk of bias for sequence generation, allocation concealment and blinding of outcome assessment.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>Two trials reported the number of diabetes-related neuropathic plantar foot ulcers healed in a total of 40 participants with 40 ulcers at 92 days (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>) (RR 2.87 95% CI 1.46 to 5.63) and 58 participants with 75 ulcers at 6 months (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>) (RR 1.3 95% 1.05 to 1.68). Both trials reported that significantly more ulcers healed in the TCC (non-removable) group. Heterogeneity was high (I<SUP>2</SUP> = 76%) therefore meta-analysis was not performed (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.1). Heterogeneity may have been due to the difference in follow up times.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>
<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK> reported the average time to healing of forefoot ulcers in the TCC group was 40.05 days and 88.5 days in the dressing group; of midfoot ulcers in the TCC group was 53 days and 95.14 days in the dressing group; and of hindfoot ulcers in the TCC group was 68.83 days and 107.33 days in the dressing group. <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>
<I>
<B> </B>
</I>randomized patients but reported on ulcers which creates a 'unit of analysis' problem. The statistical method used was not specified and as a result the information is presented narratively. <LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK> reported time to healing in a way that is difficult to interpret and therefore the reported data cannot be analysed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>In one trial (<LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK>), five of the 19 patients in the dressing group showed serious foot infections which required hospitalisation, with no infections in the non-removable cast group . Participants in the other trial (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>) were given antibiotics for minor foot infections, but no numbers or differences between the groups were reported. Five patients in the dressing group developed osteomyelitis (<LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK>). One patient who developed osteomyelitis underwent a Syme&#8217;s amputation in the <LINK REF="STD-Ganguly-2008" TYPE="STUDY">Ganguly 2008</LINK> study. <LINK REF="STD-Mueller-1989" TYPE="STUDY">Mueller 1989</LINK> reported that two patients in the dressing group required a forefoot amputation.</P>
<P>The outcomes of economic analysis, patient satisfaction and quality of life were not considered by these studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 5: Surgical interventions</HEADING>
<P>This analysis included two trials with 105 participants and 110 ulcers (<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>; <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK>). <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK> compared Achilles tendon lengthening and a total contact cast (non-removable) with a total contact cast (non-removable) alone. Both groups in this study underwent sharp surgical debridement before the intervention. <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> compared surgical debridement of the ulcer, antiseptic dressings and a therapeutic shoe with saline dressings and a therapeutic shoe. <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK> was at overall moderate risk of bias as there was low risk of bias for sequence generation and allocation concealment with no blinding of care providers or participants. Blinding of outcome assessment was stated as not possible.The risk of bias was moderate overall in <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> with adequate sequence generation, unclear allocation concealment and blinding of outcome assessment, despite attempts to contact the author.</P>
<SUBSECTION>
<HEADING LEVEL="5">Ulcer healing</HEADING>
<P>
<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK> reported diabetes-related neuropathic plantar foot ulcers healing at seven months and two years. At seven months Achilles tendon lengthening plus non-removable cast showed a statistically significant increase in the number of ulcers healed compared with the non-removable cast alone (RR 3.41, 95% CI 1.42 to 8.18) (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). This statistically significant difference was maintained at two years (RR 2.23, 95% CI 1.32 to 3.76)(<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).</P>
<P>The <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> trial reported the healing of diabetes-related neuropathic plantar foot ulcers at 6 months. Surgical debridement, antiseptic dressings and relief of weight-bearing showed no significant difference in the number of ulcers healed when compared with saline dressings and relief of weight bearing (RR of healing with surgical compared with non-surgical approaches was 1.21, 95% CI 0.96 to 1.51) (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to healing</HEADING>
<P>Time to healing in the <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> and <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK> trials were reported in a way that is difficult to interpret and therefore reported data cannot be analysed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications</HEADING>
<P>Three participants in the <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> trial reported infective complications in the saline dressings group compared with one participant in the surgical debridement group. One forefoot amputation was performed in the dressing group and was included in the six month analysis. One patient in the <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK> Achilles tendon lengthening group had a deep infection which required antibiotics and sharp debridement. One toe amputation was performed in the non-removable cast group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Patient satisfaction and quality of life</HEADING>
<P>Patient satisfaction or quality of life was not reported in <LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>. In the <LINK REF="STD-Piaggesi-1998" TYPE="STUDY">Piaggesi 1998</LINK> study patient satisfaction was reported as greater in the surgical debridement group when measured on a scale of 0-10; surgical group score 7.9 (SD 3.8) 7.9 (SD 3.8) compared with 5.4 (SD 3.1) out of a score of 0-10 compared with 5.4 (SD 3.1) in non-surgical group (not formally tested) less discomfort 1.7 (SD 1.2) compared with 2.9 for the non-surgical group<I>
<B> </B>
</I>(SD 1.8), out of a score of 1-4. Fewer limitations were reported; 1.4 (SD 1.1) compared with 3.6 (SD 2.1) for the non surgical group, out of a score of 1-4 in a self-administered questionnaire.</P>
<P>The outcome of economic analysis was not considered by these studies.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-10-24 10:22:34 +0100" MODIFIED_BY="[Empty name]">
<P>Peripheral neuropathy, when combined with increased plantar pressures plays an important role in the development of diabetes-related neuropathic foot ulceration. It is known that insufficient pressure-relief during the treatment of neuropathic foot ulcers leads to delayed wound healing.  All the included studies agree that the relief of peak pressures on plantar ulceration, represents the central point of treatment. Bed rest, wheelchairs and crutches have all been described as ineffective, primarily due to their effect on the quality of life of the patient. The reduction of plantar pressure has been described using various methods within the studies, with the current recommended methods being those that off-load the plantar surface of the foot, yet maintain some degree of mobility.</P>
<P>Although all types of diabetes-related foot ulcers were included in the search strategy, no studies were found that investigated the effect of pressure-relieving interventions on the healing of ischaemic or neuro-ischaemic ulcers. This is likely to be because these ulcers would normally be found around the outer margins or dorsum of the foot. Therefore, use of pressure-relieving devices, such as those described in this review, would be inappropriate.</P>
<P>The fourteen studies included in this review, with a total of 709 participants, investigated a range of pressure-relieving methods and devices. The studies were published over a twenty one-year period between 1989 and 2010. Most of the studies were at low risk of bias for randomisation sequence generation, and at moderate to low risk for allocation concealment. However, they were at high risk of bias for blinding, because in the majority of studies the blinding of care provider or outcome assessor was either not done or unclear. Although blinding of patients was also absent or unclear in all studies it is acknowledged that this would be difficult to achieve with this type of intervention.</P>
<P>Although the studies were randomised, most had methodological flaws: many were small with no power calculation, therefore lack of statistical power was likely. The majority of studies followed up patients for between two and six months with reporting ranging from 30 days to two years, which makes comparison of healing times difficult. </P>
<P>Some study reports did not give details about factors that might have influenced the results such as glycated haemoglobin (HbA1c), and ulcer size/duration. Nevertheless, the results of the review were strengthened by the spread of participant characteristics (such as men and women of all ages, with type 1, or type 2 diabetes of varied duration), which makes them representative of the population of people with neuropathic foot ulcers.</P>
<P>The review found that the non-removable devices were associated with a significantly higher proportion of healed ulcers than removable devices. Non-removable devices require specialist application. They reduce mobility, minimising repetitive stress and plantar pressure on the wound, when compared with removable devices. From the patient's perspective they have little choice other than to adhere to the regimen as the device is not easily removed. No bathing is allowed and there is potential for poor sleeping and postural instability. Problems were reported when using non-removable devices, such as skin irritation and the inability to check the ulcer on a daily basis. The use of instant total contact casts (non-removable) overcomes this limitation by allowing removal by the clinician for regular skin inspection. The contraindications for use of non-removable devices are soft tissue infections, osteomyelitis, severe vascular disease and severe oedema of the lower leg or foot.</P>
<P>Whilst non-removable casts are associated with more healed ulcers than removable devices anecdotally removable devices have advantages in terms of patient management and ease of use. This needs to be taken into account when assessing individuals for an off-loading device as a compromise may need to be made to achieve compliance.</P>
<P>When considering felt adhered to the skin or to the shoe for plantar pressure relief, similar healing rates were observed between the two. Felt was also found to be as effective as the temporary therapeutic half shoe for pressure relief. In both cases there is a risk of a type 2 error and this means one cannot conclude that they are equally effective. Although less effective than total contact casts and removable cast walkers, felt was reported to have some benefits over the total contact cast.  Felt can be applied in the presence of mild to moderate infection, it allows for dressings to be changed regularly and therefore the wound to be observed at each dressing change. It can be applied rapidly without the need for additional hospital appointments or specialist skill.</P>
<P>The results of both the surgical intervention studies suggest that surgery healed a higher proportion of ulcers than their non-surgical comparisons. Due to the progressive nature of diabetes and its autonomic neuropathic complications, the beneficial effect of Achilles tendon lengthening may be only relatively short term as over time the tendons are likely to shorten again and stiffen due to scar tissue formation from the surgery (<LINK REF="STD-Mueller-2003" TYPE="STUDY">Mueller 2003</LINK>). Costs and risks of surgery are considerably higher than alternative pressure relieving methods and as a result should be considered an option only if alternative methods had proved unsuccessful in the absence of evidence regarding safety and long term effectiveness.</P>
<P>The review set out to report a number of secondary outcomes including complications, patient satisfaction, quality of life and economic analysis. </P>
<P>Complications reported included infection, which is commonly associated with diabetes-related neuropathic plantar foot ulcers, and ten of the studies reported this as a secondary outcome. A greater number of infections were reported in patients with removable and non-removable devices than other methods of pressure relief, although a greater number of ulcers healed with the use of these devices.</P>
<P>Nine amputations were reported in the included studies, three of which were performed in the dressing groups; four in the non-removable cast groups; the remaining two did not specify the treatment groups.  It was therefore not possible to identify any particular trends. Those having surgical interventions as part of their ulcer treatment or succumbing to complications resulting in major infections required hospital admissions.</P>
<P>Patient engagement is crucial for any of the pressure-relieving devices to be effective in healing diabetes-related neuropathic plantar foot ulcers and gaining patient satisfaction. Some of the pressure-relieving devices, particularly the non-removable casts and removable devices, were considered cumbersome and restrictive by patients, and thus reduced mobility, which is thought to encourage ulcer healing. Since non-removable casts cannot be removed by patients themselves it ensures compliance, whereas removable devices can easily be removed by patients and so non-compliance is possible. Quality of life was not measured in any of the included trials, but this needs to be considered in future studies.</P>
<P>No cost-effectiveness studies were performed. The calculations for costs were reported in three studies, but no further details on costing were given. The higher costs of materials and increased expertise required for the application of non-removable compared with removable devices needs to be considered when formulating a treatment plan.</P>
<P>The evidence from these studies identifies that non-removable devices heal significantly more non-infected diabetes-related neuropathic plantar ulcers than removable devices or felt/foam. Contraindications are acknowledged, therefore their use has limitations and would not be suitable for all patients. The removable cast device offers a good alternative, requiring less expertise for application, allowing regular dressing changes and ulcer observations but can easily be removed by the patient indicating the potential for non-compliance.</P>
<P>The findings in this review are similar to those in a recent systematic review (<LINK REF="REF-Bus-2008" TYPE="REFERENCE">Bus 2008</LINK>). Although <LINK REF="REF-Bus-2008" TYPE="REFERENCE">Bus 2008</LINK> included non RCTs, which has the potential to introduce bias in the findings, non-removable casts were found to be the most effective intervention.  Although there is evidence in favour of non-removable casts when compared with alternative interventions, some of the comparisons described in this review included only single studies, with small numbers of participants and a number of drop outs that reduce the confidence we can have in the results. Conclusions should be cautious in the light of trial size and other methodological problems. </P>
<P>Some trials judged drop outs to be treatment failures which could cause bias. Methods of addressing missing data should be explicit and follow recognised guidance.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-10-05 08:57:02 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2011-09-16 09:59:41 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Non-removable casts provide the most effective pressure-relieving intervention for the healing of diabetic foot ulcers.</LI>
<LI>Use of this intervention has to be balanced against restrictions in movement, possible decrease in quality of life.</LI>
<LI>Where non-removable casts have been unsuccessful, other interventions, such as removable devices, adhesive felt, or surgery, may be considered.</LI>
</UL>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-10-05 08:57:02 +0100" MODIFIED_BY="[Empty name]">
<P>Based on our assessment of the included trials, we make the following recommendations:</P>
<UL>
<LI>To ensure that trial quality is adequately reported, journals should require that trials are reported according to the Consort Statement (Consolidated Statement on Reporting of Trials) (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>).</LI>
<LI>All trials should be registered with a trials register that meets the WHO criteria, and principal investigators should update their contact details on the register.</LI>
<LI>Recruitment numbers should be based on adequately powered sample size calculations.</LI>
<LI>Analysis should be by intention-to-treat of all patients following randomisation.</LI>
<LI>Economic evaluations should be incorporated into future trials.</LI>
<LI>Quality of life measures should be included.</LI>
<LI>Trials should be robust in design with adequate sequence generation, allocation concealment and blinding.</LI>
</UL>
<P>Areas for future investigation should include the slipper cast, which redistributes the pressure and immobilises the foot only. While the slipper cast is removable, it allows patient mobility and is less obtrusive than traditional casts or devices. Although it is increasingly being used for ulcer healing, currently there is little evidence to support its use.</P>
<P>Future trial comparisons could include:</P>
<P>A comparison of the slipper cast against a non-removable cast would be informative as according to the findings in this review it is the current most effective method of healing diabetic plantar neuropathic foot ulcers. In addition, replication of the comparisons in the studies included in this review taking into account the above recommendations would also provide more robust evidence.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-06-04 11:55:21 +0100" MODIFIED_BY="[Empty name]">
<P>We would like to thank:</P>
<UL>
<LI>Our employers, Cardiff and Vale University Health Board, and University of Glamorgan, respectively.</LI>
<LI>Sally Bell-Syer, the Cochrane Wounds Group Managing Editor, for her guidance.</LI>
<LI>The following people who refereed the review update for methodological quality, relevance and clarity: Jan Apelqvist, Susan O'Meara and Gill Worthy. The review was copy edited by Elizabeth Royle.</LI>
<LI>Sue Spencer whose work formed the basis for this review.</LI>
</UL>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-11-25 14:12:58 +0000" MODIFIED_BY="Elizabeth Royle">
<P>None.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-10-24 10:26:33 +0100" MODIFIED_BY="[Empty name]">
<P>Jane Lewis coordinated the review update, extracted data and checked quality of data extraction, undertook and checked quality assessment, analysed or interpreted data, performed and checked quality of statistical analysis, completed first draft of the review update, performed part of writing or editing the review, made an intellectual contribution to the update, approved the final version prior to submission, advised on the update, wrote to study authors, experts or companies, provided data and is guarantor for the review update. </P>
<P>Allyson Lipp coordinated the review update, extracted data and checked quality of data extraction, undertook and checked quality assessment, analysed or interpreted data, performed part of data analysis or interpretation, performed and checked quality of statistical analysis, completed first draft of the review update, performed part of writing or editing the review update, made an intellectual contribution, approved the final review prior to submission, advised on the update and is guarantor for the review update.</P>
<SUBSECTION>
<HEADING LEVEL="4">Contributions of editorial base:</HEADING>
<P>Nicky Cullum: edited the review and updated review, advised on methodology, interpretation and review content. Approved the final review prior to submission.<BR/>Andrea Nelson: edited the updated review and approved the final review update prior to submission.<BR/>Sally Bell-Syer: coordinated the editorial process. Advised on methodology, interpretation and content. Edited the review.<BR/>Ruth Foxlee: designed the search strategy, ran the searches and edited the search methods section.<BR/>
</P>
</SUBSECTION>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2012-10-24 10:31:59 +0100" MODIFIED_BY="[Empty name]">
<P>As a result of the restructuring of this review additional information has been added, for example, the original review stated that "The primary intervention was the relief or redistribution of pressure in the neuropathic and/or neuroischaemic diabetic foot." This included callus removal and we have now included surgical pressure-relieving interventions, e.g. shortening of the Achilles tendon.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2011-01-14 10:02:31 +0000" MODIFIED_BY="[Empty name]">
<P>The original review: Spencer SA. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002302. DOI: 10.1002/14651858.CD002302, has been substantially updated and now forms the basis of a prevention review and a separate treatment review.<BR/>The review: Pressure relieving interventions for preventing diabetic foot ulcers is currently being prepared.<BR/>This review: Pressure relieving interventions for treating diabetic foot ulcers, has been prepared by Jane Lewis and Allyson Lipp and includes only trials which consider interventions which aim to treat foot ulcers in people with diabetes. </P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-11-11 19:31:19 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-11-11 19:29:21 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-11-09 18:00:35 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Armstrong-2001" MODIFIED="2009-10-09 14:20:56 +0100" MODIFIED_BY="Elizabeth Royle" NAME="Armstrong 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-10-09 14:20:56 +0100" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB</AU>
<TI>Off-loading the diabetic foot wound: a randomized clinical trial</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>6</NO>
<PG>1019-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Armstrong-2005" MODIFIED="2009-11-27 10:55:30 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Armstrong 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-05 14:06:56 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong DG, Lavery LA, Wrobel JS, Vileikyte L</AU>
<TI>Quality of life in healing diabetic wounds: does the end justify the means?</TI>
<SO>Journal of Foot and Ankle Surgery</SO>
<YR>2008</YR>
<VL>47</VL>
<NO>4</NO>
<PG>278-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-10-09 14:21:28 +0100" MODIFIED_BY="Elizabeth Royle" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong DG, Lavery LA, Wu S, Boulton AJM</AU>
<TI>Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>3</NO>
<PG>551-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Caravaggi-2000" MODIFIED="2009-11-27 10:56:00 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Caravaggi 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-11-27 10:10:32 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caravaggi C, Faglia E, De Giglio R, Mantero M, Quarantiello A, Sommariva E, et al</AU>
<TI>Effectiveness and safety of a non-removable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers</TI>
<SO>Diabetes Care</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>12</NO>
<PG>1746-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caravaggi-2007" MODIFIED="2009-11-05 14:09:04 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Caravaggi 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-05 14:09:04 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caravaggi C, Sganzaroli A, Fabbi M, Cavaiani P, Pogliaghi I, Ferraresi R, et al</AU>
<TI>Nonwindowed nonremovable fiberglass off-loading cast versus removable pneumatic cast (AircastXP Diabetic Walker) in the treatment of neuropathic noninfected plantar ulcers: a randomized prospective trial</TI>
<SO>Diabetes Care</SO>
<YR>2007</YR>
<VL>30</VL>
<NO>10</NO>
<PG>2577-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faglia-2010" MODIFIED="2012-11-09 17:59:54 +0000" MODIFIED_BY="[Empty name]" NAME="Faglia 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-09 17:59:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faglia E, Caravaggi C, Clerici G, Sganzaroli A, Curci V, Vailati W, et al</AU>
<TI>Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer: a randomized controlled trial</TI>
<SO>Diabetes Care</SO>
<YR>2010</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1419-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ganguly-2008" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Ganguly 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ganguly S, Chakraborty K, Mandal PJ, Ballav A, Choudhury AS, Bagchi S, et al</AU>
<TI>A comparative study between total contact casting and conventional dressings in the non-surgical management of diabetic plantar foot ulcers</TI>
<SO>Journal of the Indian Medical Association</SO>
<YR>2008</YR>
<VL>106</VL>
<PG>237-9, 244</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Katz-2005" MODIFIED="2011-01-23 07:26:03 +0000" MODIFIED_BY="[Empty name]" NAME="Katz 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-23 07:26:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Katz IA, Harlan A, Miranda-Palma B, Prieto-Sanchez L, Armstrong DG, Bowker JH, et al</AU>
<TI>A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>3</NO>
<PG>555-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Mueller-1989" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" NAME="Mueller 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mueller MJ, Diamond JE, Sinacore DR, Delitto A, Blair VP 3rd, Drury DA, et al</AU>
<TI>Total contact casting in treatment of diabetic plantar ulcers</TI>
<SO>Diabetes Care</SO>
<YR>1989</YR>
<VL>12</VL>
<NO>6</NO>
<PG>384-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mueller-2003" MODIFIED="2012-11-09 18:00:35 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Mueller 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-09-15 14:27:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maluf KS, Mueller MJ, Strube MJ, Engsberg JR, Johnson JE</AU>
<TI>Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait</TI>
<SO>Journal of Biomechanics</SO>
<YR>2004</YR>
<VL>37</VL>
<NO>6</NO>
<PG>897</PG>
<IDENTIFIERS MODIFIED="2009-09-08 15:56:20 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2009-11-05 14:12:43 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mueller MJ, Sinacore DR, Hastings MK, Lott DJ, Strube MJ, Johnson JE</AU>
<TI>Impact of achilles tendon lengthening on functional limitations and perceived disability in people with a neuropathic plantar ulcer</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>7</NO>
<PG>1559-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-09 18:00:35 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE</AU>
<TI>Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial</TI>
<SO>Journal of Bone and Joint Surgery</SO>
<YR>2003</YR>
<VL>85-A</VL>
<NO>8</NO>
<PG>1436-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nube-2006" MODIFIED="2009-11-27 10:56:44 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Nube 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-09-15 14:28:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nube VL, Molyneaux L, Bolton T, Clingan T, Palmer E, Yue DK</AU>
<TI>The use of felt deflective padding in the management of plantar hallux and forefoot ulcers in patients with diabetes</TI>
<SO>The Foot: International Journal of Clinical Foot Science</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>1</NO>
<PG>38-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Piaggesi-1998" MODIFIED="2009-12-22 18:40:24 +0000" MODIFIED_BY="[Empty name]" NAME="Piaggesi 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-09-15 14:55:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piaggesi A, Rizzo L, Campi F, Schipani E</AU>
<TI>Conservative surgical approach versus non-operative treatment for diabetic neuropathic foot ulcers: a randomized trial</TI>
<SO>Journal of Endocrinological Investigation</SO>
<YR>1998</YR>
<VL>21</VL>
<NO>7 Suppl 1</NO>
<PG>193</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-12-22 18:40:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Piaggesi A, Schipani E, Campi F, Romanelli M, Baccetti C, Arvia C, et al</AU>
<TI>Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomised trial</TI>
<SO>Diabetic Medicine</SO>
<YR>1998</YR>
<VL>15</VL>
<PG>412-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Piaggesi-2007" MODIFIED="2009-11-05 14:13:59 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Piaggesi 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-05 14:13:59 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piaggesi A, Macchiarini S, Rizzo L, Palumbo F, Tedeschi A, Nobili LA, et al</AU>
<TI>An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast</TI>
<SO>Diabetes Care</SO>
<YR>2007</YR>
<VL>30</VL>
<NO>3</NO>
<PG>586-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-de-Weg-2008" MODIFIED="2009-11-05 14:15:23 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Van de Weg 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-11-05 14:15:23 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van de Weg FB, Van de Windt DA, Vahl AC</AU>
<TI>Wound healing: total contact cast vs. custom-made temporary footwear for patients with diabetic foot ulceration</TI>
<SO>Prosthetics and Orthotics International</SO>
<YR>2008</YR>
<VL>32</VL>
<NO>1</NO>
<PG>3-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Zimny-2002" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" NAME="Zimny 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zimny S, Meyer MF, Schatz H, Pfohl M</AU>
<TI>Applied felted foam for plantar pressure relief is an efficient therapy in neuropathic diabetic foot ulcers</TI>
<SO>Experimental and Clinical Endocrinology and Diabetes</SO>
<YR>2002</YR>
<VL>110</VL>
<NO>7</NO>
<PG>325-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-09-15 14:35:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimny S, Reinsch B, Schatz H, Pfohl M</AU>
<TI>Effects of felted foam on plantar pressures in the treatment of neuropathic diabetic foot ulcers</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>12</NO>
<PG>2153-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-09-11 14:09:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimny S, Schatz H, Pfohl U,</AU>
<TI>The effects of applied felted foam on wound healing and healing times in the therapy of neuropathic diabetic foot ulcers</TI>
<SO>Diabetic Medicine</SO>
<YR>2003</YR>
<VL>20</VL>
<NO>8</NO>
<PG>622-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-11-09 18:01:33 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Armstrong-1998" MODIFIED="2009-11-05 14:17:04 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Armstrong 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-11-05 14:17:04 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong DG, Lavery LA, Bushman TR</AU>
<TI>Peak foot pressures influence the healing time of diabetic foot ulcers treated with total contact casts</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>1998</YR>
<VL>35</VL>
<NO>1</NO>
<PG>1-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Birke-2002" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Birke 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Birke JA, Pavich MA, Patout CA, Horswell R</AU>
<TI>Comparison of forefoot ulcer healing using alternative off-loading methods in patients with diabetes mellitus</TI>
<SO>Advances in Skin Wound Care</SO>
<YR>2002</YR>
<VL>15</VL>
<NO>5</NO>
<PG>210-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Black-1990" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" NAME="Black 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Black JR</AU>
<TI>Management of diabetic plantar ulcers with a walking brace. A clinical trial</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>1990</YR>
<VL>80</VL>
<NO>3</NO>
<PG>156</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borssen-1989" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Borssen 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borssen B, Lithner F</AU>
<TI>Plaster casts in the management of advanced ischaemic and neuropathic diabetic foot lesions</TI>
<SO>Diabetic Medicine</SO>
<YR>1989</YR>
<VL>6</VL>
<NO>8</NO>
<PG>720-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colagiuri-1995" MODIFIED="2009-11-05 14:22:08 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Colagiuri 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-05 14:22:08 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colagiuri S</AU>
<TI>The use of orthotic devices to correct plantar callus in people with diabetes</TI>
<SO>Diabetes Research and Clinical Practice</SO>
<YR>1995</YR>
<VL>28</VL>
<PG>29-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guzman-1994" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Guzman 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guzman B, Fisher G, Palladino SJ, Stavosky JW</AU>
<TI>Pressure-removing strategies in neuropathic ulcer therapy. An alternative to total contact casting</TI>
<SO>Clinics In Podiatric Medicine And Surgery</SO>
<YR>1994</YR>
<VL>11</VL>
<NO>2</NO>
<PG>339</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartsell-2001" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Hartsell 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartsell HD, Fellner C, Saltzman CL</AU>
<TI>Pneumatic bracing and total contact casting have equivocal effects on plantar pressure relief</TI>
<SO>Foot and Ankle International</SO>
<YR>2001</YR>
<VL>22</VL>
<NO>6</NO>
<PG>502-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ha-Van-2003" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Ha Van 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ha Van G, Siney H, Hartmann-Heurtier A, Jacqueminet S, Greau F, Grimaldi A</AU>
<TI>Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>10</NO>
<PG>2848-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Helm-1991" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Helm 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Helm PA, Walker SC, Pullium GF</AU>
<TI>Recurrence of neuropathic ulceration following healing in a total contact cast</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1991</YR>
<VL>72</VL>
<NO>12</NO>
<PG>967-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lavery-1996" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" NAME="Lavery 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lavery LA, Vela SA, Lavery DC, Quebedeaux TL</AU>
<TI>Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments</TI>
<SO>Diabetes Care</SO>
<YR>1996</YR>
<VL>19</VL>
<NO>8</NO>
<PG>818-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lavery-1997" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Lavery 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lavery LA, Vela SA, Lavery DC, Quebedeaux TL</AU>
<TI>Total contact casts: pressure reduction at ulcer sites and the effect on the contralateral foot</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1997</YR>
<VL>78</VL>
<PG>1268-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-1996" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Lin 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lin SS, Lee TH, Wapner KL</AU>
<TI>Plantar forefoot ulceration with equinus deformity of the ankle in diabetic patients: the effect of tendo-achilles lengthening and total contact casting</TI>
<SO>Orthopedics</SO>
<YR>1996</YR>
<VL>19</VL>
<NO>5</NO>
<PG>465-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matricali-2003" MODIFIED="2012-11-09 18:01:33 +0000" MODIFIED_BY="[Empty name]" NAME="Matricali 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-11-09 18:01:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matricali GA, Deroo K, Dereymaeker G</AU>
<TI>Outcome and recurrence rate of diabetic foot ulcers treated by a total contact cast: short-term follow-up</TI>
<SO>Foot and Ankle International</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>9</NO>
<PG>680</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mueller-1995" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Mueller 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mueller MJ</AU>
<TI>Use of an in-shoe pressure measurement system in the management of patients with neuropathic ulcers or metatarsalgia</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>6</NO>
<PG>328-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nabuurs_x002d_Franssen-2005" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Nabuurs-Franssen 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nabuurs-Franssen MH, Sleegers R, Huijberts MS, Wijnen W, Sanders AP, Walenkamp G, et al</AU>
<TI>Total contact casting of the diabetic foot in daily practice: a prospective follow-up study</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>2</NO>
<PG>243</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salsich-2005" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Salsich 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salsich GB, Mueller MJ, Hastings MK, Sinacore DR, Strube MJ, Johnson JE</AU>
<TI>Effect of Achilles tendon lengthening on ankle muscle performance in people with diabetes mellitus and a neuropathic plantar ulcer</TI>
<SO>Physical Therapy</SO>
<YR>2005</YR>
<VL>85</VL>
<NO>1</NO>
<PG>34-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Samanta-1989" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Samanta 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Samanta A, Burden AC, Sharma A, Jones GR</AU>
<TI>A comparison between 'LSB' shoes and 'space' shoes in diabetic foot ulceration</TI>
<SO>Practical Diabetes</SO>
<YR>1989</YR>
<VL>6</VL>
<NO>1</NO>
<PG>26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Tyrrell-1998" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NAME="Tyrrell 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Tyrrell W, Phillips C, Gibby O, Price P</AU>
<TI>An investigation into the therapeutic effectiveness and cost effectiveness of orthotic therapy provided for those attending the diabetic foot clinic at Richmond House Diabetes Centre</TI>
<SO>Report for Wales Office of Research and Development for Health and Social Care</SO>
<YR>1998</YR>
<PG>1-44</PG>
<PB>Royal Gwent Hospital,</PB>
<CY>Newport</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-09-15 15:05:12 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uccioli-1995" MODIFIED="2009-11-05 14:36:50 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Uccioli 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-05 14:36:50 +0000" MODIFIED_BY="Elizabeth Royle" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uccioli L, Faglia E, Monticone G, Faveles F, Durola L, Aldeghi A, et al</AU>
<TI>Manufactured shoes in the prevention of diabetic foot ulcers</TI>
<SO>Diabetes Care</SO>
<YR>1995</YR>
<VL>18</VL>
<NO>10</NO>
<PG>1376-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-11-11 19:29:21 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gutekunst-2011" MODIFIED="2012-07-13 11:59:35 +0100" MODIFIED_BY="[Empty name]" NAME="Gutekunst 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-07-13 11:59:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gutekunst DJ, Hastings MK, Bohnert KL, Strube MJ, Sinacore DR</AU>
<TI>Removable cast walker boots yield greater forefoot off-loading than total contact casts</TI>
<SO>Clinical Biomechanics</SO>
<YR>2011</YR>
<VL>26</VL>
<NO>6</NO>
<PG>649-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vallini-2012" MODIFIED="2012-11-11 19:29:21 +0000" MODIFIED_BY="[Empty name]" NAME="Vallini 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-11 19:29:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vallini V, Piaggesi A, Iacopi E, Clerici G , Romagnoli F, Toscanella F, et al</AU>
<TI>Three different modalities for offloading the neuropathic ulcerated foot: a multicenter prospective randomized trial</TI>
<SO>EWMA Journal </SO>
<YR>2012</YR>
<VL>12</VL>
<NO>2</NO>
<PG>27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2009-07-22 12:05:06 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Agas-2006" MODIFIED="2009-07-22 12:05:06 +0100" MODIFIED_BY="[Empty name]" NAME="Agas 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-22 12:05:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agas CM, Bul TD, Driver VR, Gordon IL</AU>
<TI>Effect of window casts on healing rates of diabetic foot ulcers</TI>
<SO>Journal of Wound Care</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>2</NO>
<PG>80-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-11-11 19:31:19 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-11-11 19:31:19 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abbott-1998" MODIFIED="2009-06-10 14:11:37 +0100" MODIFIED_BY="[Empty name]" NAME="Abbott 1998" TYPE="JOURNAL_ARTICLE">
<AU>Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ</AU>
<TI>Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration</TI>
<SO>Diabetes Care</SO>
<YR>1998</YR>
<VL>21</VL>
<PG>1071-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Abbott-2002" MODIFIED="2009-08-25 15:11:09 +0100" MODIFIED_BY="[Empty name]" NAME="Abbott 2002" TYPE="JOURNAL_ARTICLE">
<AU>Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al</AU>
<TI>The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort</TI>
<SO>Diabetes Medicine</SO>
<YR>2002</YR>
<VL>19</VL>
<PG>377-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ADA-1996" MODIFIED="2009-11-05 14:39:45 +0000" MODIFIED_BY="Elizabeth Royle" NAME="ADA 1996" TYPE="BOOK">
<AU>Amercian Diabetes Association</AU>
<SO>Diabetes vital statistics</SO>
<YR>1996</YR>
<PB>American Diabetes Association</PB>
<CY>Alexandria VA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ADA-2000" MODIFIED="2009-11-05 14:40:02 +0000" MODIFIED_BY="Elizabeth Royle" NAME="ADA 2000" TYPE="BOOK">
<AU>American Diabetes Association</AU>
<SO>Diabetes facts and figures</SO>
<YR>2000</YR>
<PB>American Diabetes Association</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anonymous-2002" MODIFIED="2010-01-27 15:45:48 +0000" MODIFIED_BY="[Empty name]" NAME="Anonymous 2002" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Cost of diabetic foot ulcers</TI>
<SO>Nursing Economics</SO>
<YR>2002</YR>
<VL>January</VL>
<PG>?</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Armstrong-2003" MODIFIED="2010-01-18 09:36:29 +0000" MODIFIED_BY="[Empty name]" NAME="Armstrong 2003" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJ</AU>
<TI>Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>9</NO>
<PG>2595-2597</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boulton-1996" MODIFIED="2009-11-05 14:40:30 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Boulton 1996" TYPE="JOURNAL_ARTICLE">
<AU>Boulton A</AU>
<TI>The pathogenesis of diabetic foot problems: an overview</TI>
<SO>Diabetic Medicine</SO>
<YR>1996</YR>
<VL>13</VL>
<NO>Supp 1</NO>
<PG>S12-S16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boulton-2001" MODIFIED="2009-11-05 14:40:47 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Boulton 2001" TYPE="JOURNAL_ARTICLE">
<AU>Boulton AJ</AU>
<TI>The diabetic foot</TI>
<SO>Diabetic Monitor</SO>
<YR>2001</YR>
<VL>13</VL>
<NO>1</NO>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boulton-2004" MODIFIED="2009-11-05 14:43:05 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Boulton 2004" TYPE="JOURNAL_ARTICLE">
<AU>Boulton AJ</AU>
<TI>Pressure and the diabetic foot: clinical science and offloading techniques</TI>
<SO>American Journal of Surgery</SO>
<YR>2004</YR>
<VL>187</VL>
<NO>5A</NO>
<PG>17S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boyko-1999" MODIFIED="2010-05-05 15:17:42 +0100" MODIFIED_BY="[Empty name]" NAME="Boyko 1999" TYPE="JOURNAL_ARTICLE">
<AU>Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG</AU>
<TI>A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study</TI>
<SO>Diabetes Care</SO>
<YR>1999</YR>
<VL>22</VL>
<PG>1036-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bus-2008" MODIFIED="2009-11-06 10:05:19 +0000" MODIFIED_BY="Elizabeth Royle" NAME="Bus 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bus SA, Valk GD, van Deursen RW, Armstrong DG, Caravaggi C, Hlavacek P, et al</AU>
<TI>The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review</TI>
<SO>Diabetes/Metabolism Research And Reviews</SO>
<YR>2008</YR>
<VL>24 Suppl 1</VL>
<PG>S162</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cantanzariti-1999" MODIFIED="2011-02-03 09:52:51 +0000" MODIFIED_BY="[Empty name]" NAME="Cantanzariti 1999" TYPE="JOURNAL_ARTICLE">
<AU>Cantanzariti AR, Haverstock BD, Grossman JP, Mendicino RW  </AU>
<TI>Off-loading techniques in the treatment of diabetic plantar neuropathic foot ulceration</TI>
<SO>Advances in Wound Care</SO>
<YR>1999</YR>
<VL>January</VL>
<PG>452-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cavanagh-1994" MODIFIED="2009-06-12 16:19:10 +0100" MODIFIED_BY="[Empty name]" NAME="Cavanagh 1994" TYPE="BOOK_SECTION">
<AU>Cavanagh PR, Ulbrecht JS</AU>
<TI>Biomechanical aspects of foot problems in diabetes</TI>
<SO>The Foot in Diabetes</SO>
<YR>1994</YR>
<PG>25-36</PG>
<ED>Boulton AJM, Connor H, Cavanagh PR</ED>
<PB>John Wiley and Sons</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDCP-2005" MODIFIED="2009-11-06 10:06:21 +0000" MODIFIED_BY="Elizabeth Royle" NAME="CDCP 2005" TYPE="OTHER">
<AU>Centres for Disease Control and Prevention</AU>
<TI>Data and trends: National Diabetes Surveillance System</TI>
<SO>National Centre for Chronic Disease Prevention and Health Promotion, Atlanta</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coles-2004" MODIFIED="2009-06-10 14:18:45 +0100" MODIFIED_BY="[Empty name]" NAME="Coles 2004" TYPE="JOURNAL_ARTICLE">
<AU>Coles DR, Coppini DV</AU>
<TI>Survey of hospital admissions related to diabetic foot disease</TI>
<SO>Diabetic Foot</SO>
<YR>2004</YR>
<VL>7</VL>
<NO>1</NO>
<PG>47-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Frykberg-1998" MODIFIED="2009-09-15 15:13:06 +0100" MODIFIED_BY="[Empty name]" NAME="Frykberg 1998" TYPE="BOOK_SECTION">
<AU>Frykberg RG, Habershaw GM, Chrzan JS</AU>
<TI>Epidemiology of the diabetic foot: ulcerations and amputations</TI>
<SO>Contemporary Endocrinology: Clinical Management of Diabetic Neuropathy</SO>
<YR>1998</YR>
<ED>Veves A</ED>
<PB>Humana Press</PB>
<CY>New Jersey</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Giurini-1995" MODIFIED="2010-05-05 15:17:58 +0100" MODIFIED_BY="[Empty name]" NAME="Giurini 1995" TYPE="JOURNAL_ARTICLE">
<AU>Giurini JM, Rosenblum BI</AU>
<TI>The role of foot surgery in patients with diabetes</TI>
<SO>Clinics in Podiatric Medicine and Surgery</SO>
<YR>1995</YR>
<VL>12</VL>
<PG>119-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2012-03-30 16:24:02 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>JPT Higgins, SG Thompson, JJ Deeks, DG Altman</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>British Medical Journal</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-03-30 16:23:37 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<EN>Version 5.0.0</EN>
<ED>JPT Higgins, S Green</ED>
<PB>Cochrane Collaboration</PB>
<CY>Available from www.cochrane-handbook.org</CY>
<IDENTIFIERS MODIFIED="2009-12-21 13:13:19 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-IDF-2003" MODIFIED="2009-06-10 14:13:12 +0100" MODIFIED_BY="[Empty name]" NAME="IDF 2003" TYPE="BOOK">
<AU>International Diabetes Federation</AU>
<SO>IDF Diabetes Atlas</SO>
<YR>2003</YR>
<PB>International Diabetes Federation</PB>
<CY>Belgium</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jeffcoate-2005" MODIFIED="2009-09-15 15:14:09 +0100" MODIFIED_BY="[Empty name]" NAME="Jeffcoate 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jeffcoate WJ</AU>
<TI>The incidence of amputation in diabetes</TI>
<SO>Acta Chirurgica Belgica</SO>
<YR>2005</YR>
<VL>105</VL>
<NO>2</NO>
<PG>140-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kumar-1994" MODIFIED="2009-06-10 14:26:53 +0100" MODIFIED_BY="[Empty name]" NAME="Kumar 1994" TYPE="JOURNAL_ARTICLE">
<AU>Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, et al</AU>
<TI>The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study</TI>
<SO>Diabetes Medicine</SO>
<YR>1994</YR>
<VL>11</VL>
<NO>5</NO>
<PG>480-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Larsson-1998" MODIFIED="2009-06-10 14:49:56 +0100" MODIFIED_BY="[Empty name]" NAME="Larsson 1998" TYPE="JOURNAL_ARTICLE">
<AU>Larsson J, Agardh CD, Apelqvist J, Stenstrom A</AU>
<TI>Long-term prognosis after healed amputation in patients with diabetes</TI>
<SO>Clinical Orthopaedics</SO>
<YR>1998</YR>
<VL>350</VL>
<PG>149-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2012-03-30 16:14:21 +0100" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group</AU>
<TI>Chapter 6: Searching for studies</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Macfarlane-1997" MODIFIED="2009-05-06 11:28:25 +0100" MODIFIED_BY="[Empty name]" NAME="Macfarlane 1997" TYPE="JOURNAL_ARTICLE">
<AU>Macfarlane RM, Jeffcoate WJ</AU>
<TI>Factors contributing to the presentation of diabetic foot ulcers</TI>
<SO>Diabetic Medicine</SO>
<YR>1997</YR>
<VL>14</VL>
<PG>867-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2010-05-05 15:21:30 +0100" MODIFIED_BY="[Empty name]" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials</TI>
<SO>BMC Medical Research Methodology</SO>
<YR>2001</YR>
<VL>1</VL>
<NO>2</NO>
<PG>1-7</PG>
<IDENTIFIERS MODIFIED="2010-05-05 15:19:35 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-05-05 15:19:35 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1471-2288-1-2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ndip-2009" MODIFIED="2009-06-10 14:52:20 +0100" MODIFIED_BY="[Empty name]" NAME="Ndip 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ndip A, Jude EB</AU>
<TI>Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice</TI>
<SO>International Journal of Lower Extremity Wounds</SO>
<YR>2009</YR>
<VL>8</VL>
<NO>2</NO>
<PG>82-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Needleman-1997" MODIFIED="2012-03-30 16:30:59 +0100" MODIFIED_BY="[Empty name]" NAME="Needleman 1997" TYPE="JOURNAL_ARTICLE">
<AU>Needleman RL</AU>
<TI>Successes and pitfalls in the healing of neuropathic forefoot ulcerations with the IPOS Postoperative Shoe</TI>
<SO>Foot and Ankle International</SO>
<YR>1997</YR>
<VL>18</VL>
<PG>412-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reiber-1995" MODIFIED="2009-06-12 16:18:30 +0100" MODIFIED_BY="[Empty name]" NAME="Reiber 1995" TYPE="BOOK_SECTION">
<AU>Reiber GE, Boyko EJ, Smith DG</AU>
<TI>Lower extremity foot ulcers and amputations in diabetes</TI>
<SO>Diabetes in America</SO>
<YR>1995</YR>
<PG>409-27</PG>
<ED>Harris MI, Cowie C, Stern MP</ED>
<PB>NIH Publication</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reiber-1996" MODIFIED="2009-09-15 15:14:44 +0100" MODIFIED_BY="[Empty name]" NAME="Reiber 1996" TYPE="JOURNAL_ARTICLE">
<AU>Reiber GE</AU>
<TI>The epidemiology of diabetic foot problems</TI>
<SO>Diabetic Medicine</SO>
<YR>1996</YR>
<VL>13</VL>
<NO>Supp 1</NO>
<PG>S6-S11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reiber-2001" MODIFIED="2009-06-12 16:16:21 +0100" MODIFIED_BY="[Empty name]" NAME="Reiber 2001" TYPE="BOOK_SECTION">
<AU>Reiber GE</AU>
<TI>Epidemiology of foot ulcers and amputations in the diabetic foot</TI>
<SO>The Diabetic Foot</SO>
<YR>2001</YR>
<PG>13-32</PG>
<ED>Bowker JH, Pfeifer MA</ED>
<PB>Mosby</PB>
<CY>St Louis</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenblum-1994" MODIFIED="2010-05-05 15:21:47 +0100" MODIFIED_BY="[Empty name]" NAME="Rosenblum 1994" TYPE="JOURNAL_ARTICLE">
<AU>Rosenblum BI, Pomposelli FB, Giurini JM, Gibbons GW, Freeman DV, Chrzan JS</AU>
<TI>Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes: A 5-year experience</TI>
<SO>Diabetes Care</SO>
<YR>1994</YR>
<VL>17</VL>
<PG>983-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SIGN-2011" MODIFIED="2012-03-30 16:05:26 +0100" MODIFIED_BY="[Empty name]" NAME="SIGN 2011" TYPE="OTHER">
<AU>Scottish Intercollegiate Guidelines Network (SIGN)</AU>
<TI>Search filters</TI>
<SO>http://www.sign.ac.uk/methodology/filters.html#random</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wild-2004" MODIFIED="2009-06-10 14:13:51 +0100" MODIFIED_BY="[Empty name]" NAME="Wild 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wild S, Roglic G, Green A, Sicree R, King H</AU>
<TI>Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<PG>1047-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams-2003" MODIFIED="2009-09-15 15:15:03 +0100" MODIFIED_BY="[Empty name]" NAME="Williams 2003" TYPE="JOURNAL_ARTICLE">
<AU>Williams DT, Price P, Harding KG</AU>
<TI>The clinical evaluation of lower limb perfusion in diabetic foot disease</TI>
<SO>The British Journal of Diabetes and Vascular Disease</SO>
<YR>2003</YR>
<VL>2</VL>
<NO>6</NO>
<PG>394-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Young-1991" MODIFIED="2012-03-30 16:31:10 +0100" MODIFIED_BY="[Empty name]" NAME="Young 1991" TYPE="JOURNAL_ARTICLE">
<AU>Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJM</AU>
<TI>The effect of callous removal on dynamic foot pressures in diabetic patients</TI>
<SO>Diabetic Medicine</SO>
<YR>1991</YR>
<VL>9</VL>
<PG>55-7</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2011-09-14 15:36:31 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Spencer-2000" MODIFIED="2011-09-14 15:36:31 +0100" MODIFIED_BY="[Empty name]" NAME="Spencer 2000" TYPE="COCHRANE_REVIEW">
<AU>Spencer SA</AU>
<TI>Pressure relieving interventions for preventing and treating diabetic foot ulcers</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-09-14 15:36:31 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-09-14 15:36:31 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002302"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2009-06-15 08:37:05 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-11-09 17:58:13 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Armstrong-2001">
<CHAR_METHODS MODIFIED="2010-06-29 07:17:35 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-22 18:10:13 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 75 US, community-based patients with diabetes and a plantar foot ulcer.<BR/>25 patients in each group.<BR/>Inclusion criteria: VPT &gt; 25 volts.<BR/>At least one palpable foot pulse or transcutaneous oximetry &gt; 40 mmHg; diabetes-related neuropathic plantar foot ulcer Texas Wound Classification A1.<BR/>Exclusion criteria: active infection; unable to walk; heel, rear foot wounds or in location other than plantar; severe peripheral vascular disease (absence of foot pulse on affected limb).<BR/>Baseline comparability: sex, duration of diabetes, TcPO<SUB>2</SUB>, wound size, wound duration, VPT.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-22 14:50:29 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1. total contact cast (TCC, non-removable cast);<BR/>Group 2. removable cast walker (RCW, Aircast Diabetic Walker, removable device);<BR/>Group 3. half shoe (Darco, temporary therapeutic half shoe).</P>
<P>TCCs were applied using a modified technique and changed on a weekly basis or as clinically necessary. RCWs and half shoes were applied using directions supplied. All patients were instructed to use the device at all times during ambulation and the device was inspected weekly. All wounds were debrided as required on each visit.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-06-22 14:59:22 +0100" MODIFIED_BY="[Empty name]">
<P>Complete epithelialisation or at 12 weeks which ever came first.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>Largest wound used as index ulcer. <BR/>Funding: Quote: "This study was funded by the US Department of Veterans Affairs' Rehabilitation R&amp;D Merit Award Grant A2150RC and the Aircast Research Foundation".</P>
<P>Comment: It is possible that funding from the organisation which produces the pressure relieving devices could have influenced the outcomes.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-06-14 15:37:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Armstrong-2005">
<CHAR_METHODS MODIFIED="2010-06-29 07:35:12 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-06-29 08:12:58 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 50 US, community-based patients with diabetes and a plantar foot ulcer.<BR/>27 patients in group 1 and 23 patients in group 2.<BR/>Inclusion criteria: VPT &gt; 25 volts; at least one palpable foot pulse; neuropathic plantar diabetic foot ulcer Texas Wound Classification A1.<BR/>Exclusion criteria: active infection; unable to walk; heel, rear foot wounds or in location other than plantar; severe peripheral vascular disease (absence of foot pulse on affected limb).<BR/>Baseline comparability for age, sex, BMI, wound size, VPT, and HbA1c.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-22 14:49:32 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: removable cast walker (RCW, Active Offloading Walker, removable device);<BR/>Group 2: instant total contact cast (iTCC, Active Offloading Walker, non-removable device).</P>
<P>iTCC was an RCW wrapped entirely in a cohesive bandage creating an 'instant' non-removable cast. All patients were instructed to use the device at all times during ambulation and the device was inspected weekly. All wounds were debrided as required on each visit.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-20 13:46:02 +0100" MODIFIED_BY="[Empty name]">
<P>Complete epithelialisation or at 12 weeks.<BR/>Secondary outcomes: infection; skin maceration.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:37:30 +0100" MODIFIED_BY="[Empty name]">
<P>Largest ulcer used as index ulcer.<BR/>Funding: Quote: "Supported by the US Department of Veterans Affairs, Health Services Research and Development Award IIR 20-059 and the Rehabilitation Research and Development Merit Award A2150RC".</P>
<P>Comment: It is unlikely that funding from this organisation could have influenced the outcomes.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-22 18:11:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caravaggi-2000">
<CHAR_METHODS MODIFIED="2009-11-04 11:28:20 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-22 18:11:00 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 50 Italian, community-based patients with diabetes and a neuropathic foot ulcer.<BR/>24 patients in group 1 and 26 patients in group 2.<BR/>Inclusion criteria: insensitive to 10 g Semmes Weinstein monofilament; VPT &gt; 25 V  measured on malleolus.<BR/>Exclusion criteria: deep or superficial tissue infection, or underlying osteomyelitis; TcPO<SUB>2</SUB> &lt; 30 mmHg; ABPI &lt; 0.6; severe problems with equilibrium; severe visual deficit; other lesions or bilateral ulceration of the foot or amputation of a limb.<BR/>Baseline comparability for age, sex, diabetes treatment, prior lesions, BMI, smoking, hypertension, retinopathy, renal impairment, and TcPO<SUB>2</SUB>.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-27 10:26:38 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: shoe (temporary therapeutic shoe);<BR/>Group 2: cast (non-removable cast).</P>
<P>The temporary therapeutic shoes had a rigid rocker-bottom sole with unloading insole. All patients used the same shoe with no area of off-loading on the unaffected foot. The non-removable off-loading cast was custom-made for each patient in-house with fibreglass bandages of variable rigidity with an open window directly above the ulcer. An aluminium stirrup or rubber heel was added to allow walking. The sole of the shoe on the unaffected foot was elevated to ease walking.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-06-22 14:59:35 +0100" MODIFIED_BY="[Empty name]">
<P>Healing measured at 30 days.<BR/>Criteria for healing not stated.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:37:39 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: not stated<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-06-14 15:38:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caravaggi-2007">
<CHAR_METHODS MODIFIED="2010-05-14 14:43:49 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-07-27 09:25:25 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 58 Italian, community-based patients with diabetes and neuropathic plantar ulcers.<BR/>29 patients in group 1 and 29 patients in group 2.<BR/>Inclusion criteria: neuropathic plantar ulcers including Charcot neuropathy ulcers; peripheral neuropathy; insensitivity to 10 g monofilament; VPT &gt; 25 volts.<BR/>Exclusion criteria: superficial tissue infection, osteomyelitis; TcPO<SUB>2</SUB> &lt; 30 mmHg; ABPI &lt; 0.6; severe visual deficit; severe problems with equilibrium; bilateral plantar ulcers, or amputation of the contralateral limb.<BR/>Baseline comparability for age, sex, type and duration of diabetes, position and size of ulcer.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-22 15:08:27 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: Aircast Pneumatic Walker (APW, removable);<BR/>Group 2: fibreglass pressure-relieving cast (non-removable cast).</P>
<P>APW was an off-loading device with a semi-rigid plastic shell surrounding the limb with a removable front panel for access to the ulcer. It has four internal inflated air cells and a rocker sole. A hole was made in the insole at the ulcer site to off-load the ulcer. The non-removable cast comprised tubular stockinet and German cotton covered with one of two types of fibreglass bandage and a walking stirrup or rubber heel to allow walking.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-06-22 15:08:38 +0100" MODIFIED_BY="[Empty name]">
<P>Healing measured at 90 days.<BR/>Criteria for healing not stated.<BR/>Secondary outcomes: infection.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:38:02 +0100" MODIFIED_BY="[Empty name]">
<P>One patient excluded from each group due to non-concordance. <BR/>Funding: Quote: "Aircast company provided the pneumatic casts free of charge".</P>
<P>Comment: information provided by author. It is possible that funding from the organisation which produces the pressure relieving devices could have influenced the outcomes.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-24 10:32:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Faglia-2010">
<CHAR_METHODS MODIFIED="2011-08-31 08:59:09 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-09-14 12:28:19 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 48 Italian patients with a diabetic plantar foot ulcer.</P>
<P>25 patients in group 1 and 23 patients in group 2.</P>
<P>Inclusion criteria: Negative probe to bone manoeuvre and standard x-ray for osteomyelitis.</P>
<P>Exclusion criteria: presence of ankle-brachial pressure index &lt;0.9 and/or transcutaneous oxygen tension &lt;50mmHg tested on the dorsum of the foot. Clinical signs of infection. Use of steroids and antimitotic drugs, visual problems impairing balance, active ulcer or major amputation of other limb, current or previous DVT of the leg or mental disorder interfering with patient compliance.</P>
<P>Baseline comparability for age, sex, duration of diabetes, BMI, HbA1c, previous foot ulcer, minor amputation and mean area of ulcer.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-24 10:32:00 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1 Total Contact Cast (TCC, non-removable cast)<BR/>Group 2 Removable Cast Walker (RCW, Stabil-D)</P>
<P>On the initial visit, ulcers were debrided to remove all non-viable tissue and to expose the entire surface of the lesion in both groups. In group 1 TCCs were made by personnel with specific expertise and applied as described in <LINK REF="STD-Caravaggi-2000" TYPE="STUDY">Caravaggi 2000</LINK>. Two types of fibreglass bandages were applied over German cotton and tubular stockinet. Protective foam rubber was placed over bony protrusions. A Scotchcast bandage was then applied in addition to an aluminium stirrup to allow walking. In group 2 the Stabil-D was composed of a specifically designed rigid, boat-shaped and fully rocker bottom sole with rounded extremities. The modular insole is designed to allow offloading by removal of small inserts over the ulcer site. In both groups patients were trained in care of the device and walking.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-31 11:46:53 +0100" MODIFIED_BY="[Empty name]">
<P>Decrease in ulcer size<BR/>Rate of complete healing (epithelialization) at study completion.</P>
<P>Secondary outcomes: costs.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-22 19:51:33 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: Quote: "We acknowledge the contribution of Podartis, Montebelluna,Treviso, Italy, manufacturers of the Stabil-D walkers used in this study".</P>
<P>Comment: As the manufacturers of the RCWs used in the study it is judged possible that the grant could have influenced the results.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-04 09:20:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ganguly-2008">
<CHAR_METHODS MODIFIED="2009-11-04 11:46:20 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-04 09:20:22 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 58 Indian, community-based patients with diabetes with one or more plantar foot ulcers.<BR/>39 ulcers in 29 patients in group 1 and 36 ulcers in 29 patients in group 2.<BR/>Inclusion criteria: plantar ulcers grades 1 and 2 (depth) (modified Wagner) grades A and B (ischaemia) (authors' own classification); insensitivity to 10 g Semmes-Weinstein monofilament sensitivity test.<BR/>Exclusion criteria: plantar ulcers grade 3 (depth) (modified Wagner) grades C and D (ischaemia) (authors' own classification); fragile skin; excessive pedal oedema; non-compliance/concordance; unsafe mobility with cast.<BR/>Baseline comparability: none stated.<BR/>Unit of analysis - This trial randomized patients but reported on ulcers. Multiple ulcers on one patient cannot be stated as independent of each other as claimed by the study authors.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-29 09:50:24 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: total contact cast (TCC, non-removable cast);<BR/>Group 2: gauze dressing.</P>
<P>Group 1 patients had 'meticulous, sharp debridement' 'and the wound was dressed with normal saline and lightly packed with moist gauze. Plaster of paris cast was applied' with the sole of a slipper forming a rocker-bottom. Group 2 comprised a 'simple' dressing with mupirocin ointment and sterile gauze after cleansing with normal saline. Dressings were changed by the patients' relatives every 48 hours and they returned for weekly check ups (or more often if required). Patients were advised to use 'custom-made footwear' on the affected foot.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-07-27 09:25:43 +0100" MODIFIED_BY="[Empty name]">
<P>Complete epithelialisation and follow up for 6 months afterwards.<BR/>Secondary outcomes: infection; amputation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-22 19:58:13 +0100" MODIFIED_BY="[Empty name]">
<P>Study included forefoot, midfoot and heel ulcers. Funding: not stated.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-22 20:01:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Katz-2005">
<CHAR_METHODS MODIFIED="2011-01-23 08:41:32 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-22 20:01:52 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 41 patients with diabetes and a neuropathic foot ulcer.<BR/>21 patients in group1 and 20 patients in group 2.<BR/>Inclusion criteria: Chronic (present for 7&gt; days with a surrounding area of callus), non ischaemic, noninfected ulcers, Texas wound classification of IA or IIA , neuropathy disability score of 6&gt; and a vibration perception threshold score of &gt;25 volts.</P>
<P>Exclusion criteria: active infection at ulcer site, active Charcot neuroarthropathy, significant peripheral arterial disease (absent dorsalis pedis or posterior tibial pulse), inability to walk.</P>
<P>Baseline comparability: age, gender, ethnicity, diabetes type and duration, smoker, VPT, neuropathy disability score, ulcer area, duration and distribution.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-22 16:03:35 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: instant total contact cast (iTCC, Active Offloading Walker, non-removable cast).<BR/>Group 2: total contact cast (TCC, non-removable cast).</P>
<P>All wounds were assessed, debrided after which the casts were applied. A removable cast walker was rendered non-removable by wrapping it with a single layer of fibreglass casting material to make an instant total contact cast (iTCC) which were applied to patients in Group 1. Group 2 were administered a standard non-removable total contact cast. All patients were followed up weekly and the device inspected and removed. The wounds were then inspected, sharply debrided as necessary, measured, traced, photographed and the device reapplied.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-09-16 10:16:42 +0100" MODIFIED_BY="[Empty name]">
<P>Healing measured up to 12 weeks as proportion of ulcers healed.<BR/>Criteria for healing was complete epithelialisation.<BR/>Secondary outcomes: Maceration, second ulcer, toe amputation, costs.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:38:34 +0100" MODIFIED_BY="[Empty name]">
<P>If the person had more than one ulcer, the largest one was considered the index ulcer for study purposes.<BR/>Funding: Quote: " We acknowledge the generous contribution by Royce Medical, Camarillo, California of the DH Walker, the removable cast walkers used in this study".</P>
<P>Comment: It is possible that funding from the organisation which produces one of the pressure relieving devices could have influenced the outcomes.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-22 20:08:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mueller-1989">
<CHAR_METHODS MODIFIED="2012-09-22 20:08:37 +0100" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-31 11:41:02 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 40 US, community-based patients with diabetes and plantar foot ulcers.<BR/>21 patients in group 1 and 19 patients in group 2.<BR/>Inclusion criteria: diabetes type 1 or type 2; plantar ulcer; neuropathic ulcer.<BR/>Exclusion criteria: osteomyelitis; gross infection; gangrene.</P>
<P>Baseline comparability: age, gender, type of diabetes, ulcer duration, size, sensation and vascular disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-22 13:31:45 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: total contact cast (TCC, non-removable cast);<BR/>Group 2: traditional dressing treatment (TDT plus 'accommodative footwear').</P>
<P>In group 1 cotton was placed between the toes to prevent maceration with felt padding to protect bony prominences. A TCC was custom-made with plaster, reinforced with splints and fibreglass. A walking heel was attached to the plantar surface. Ambulation limited to 33% of usual activity. TCCs were reapplied after 5-7 days and skin inspected. If no complications the TCC was reapplied every 2-3 weeks until ulcer healed. Group 2 patients' ulcers were covered in a 'wet to dry' sterile saline dressing. Patients were instructed to change it 2-3 times a day with help of home-health nurse if needed. All patients were prescribed accommodative footwear and instructed to avoid weight bearing by using crutches or walkers. Patients followed up every 2-4 weeks for routine wound care and debridement.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-20 13:45:44 +0100" MODIFIED_BY="[Empty name]">
<P>Complete skin coverage and no drainage at 92 days (i.e. 13.1 weeks or 3.3 months).<BR/>Secondary outcomes: infection; compliance/concordance; admission to hospital.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:38:51 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: Quote: "This study was supported by a grant from the Foundation for Physical Therapy".</P>
<P>Comment: As a non-profit making organisation it is judged unlikely that the grant would have influenced the results.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-06-14 15:39:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mueller-2003">
<CHAR_METHODS MODIFIED="2009-11-04 14:36:14 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-31 11:41:14 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 64 US, community-based patients with diabetes and a neuropathic plantar ulcer.<BR/>31 patients in group1 and 33 patients in group 2.<BR/>Inclusion criteria: insensitive to 10 g Semmes-Weinstein monofilament; limitation of ankle dorsiflexion to &lt; 5 degrees; VPT &gt; 25 volts measured on malleolus.<BR/>Exclusion criteria: neurobiological problem complicating the rehabilitation; history of Charcot fractures of the hind foot; unable to tolerate anaesthetic; would not benefit from  ATL (i.e. not able to walk). </P>
<P>Baseline comparability: age, sex, type and duration of diabetes, BMI, HbA1c, previous ulcers, and ulcer size.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-30 10:18:05 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: total contact cast and Achilles tendon lengthening (TCC + ATL) (surgery plus non-removable cast);<BR/>Group 2: total contact cast (TCC, non-removable cast).</P>
<P>Necrotic tissue was removed, ulcers sharply debrided and covered with dry gauze in all patients. The Achilles tendon was lengthened in all Group 1 patients under sedation and local anaesthetic. Afterwards a TCC was applied with the distal end of the toe box left open and a standard rocker cast applied rather than a walking heel progressing to full weight-bearing after a week when the cast was changed.The affected foot was placed in a padded diabetic pressure-relief walking boot. Group 2 patients had a TCC applied with full weight-bearing but limited activity. In both groups the cast was changed every 2-3 weeks until healing.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-07-16 15:16:33 +0100" MODIFIED_BY="[Empty name]">
<P>Complete epithelialisation at 7 months and complete epithelialisation at 2 years.<BR/>Secondary outcomes: infection; amputation; compliance/concordance; mortality.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>Charcot deformity of mid or forefoot or partial foot amputation not excluded.<BR/>Power calculation predicted need for 100 patients. Effect size greater than anticipated, resulted in early termination of study.<BR/>Funding: Quote: "One or more authors received funding from National Center for Medical Rehabilitation Research and the National Institutes for Health ROI HD 36802. None of the authors received payments or other benefits to any research fund, foundation, educational institution, or other charitable nonprofit organization with which the authors are affiliated or associated".</P>
<P>Comment: It is unlikely that funding from this organisation could have influenced the outcomes.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-06-14 15:39:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nube-2006">
<CHAR_METHODS MODIFIED="2009-11-04 14:42:30 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-31 11:41:47 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 38 Australian community-based patients with diabetes and a neuropathic plantar ulcer.<BR/>19 patients in group 1 and 19 patients in group 2.<BR/>Inclusion criteria: Type 1 or 2 diabetes; neuropathy; plantar ulceration of hallux or metatarsal area; Texas Wound Classification A1 or B1.<BR/>Exclusion criteria: non-palpable pulses or ABPI &lt; 0.6; highly exudative ulcer; deep sinus.</P>
<P>Baseline comparability: Imbalance for ulcer duration and HbA1c.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-30 10:42:22 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: felt deflective padding directly to foot (felt to foot);<BR/>Group 2: felt deflective padding to insole of shoe (felt to shoe).</P>
<P>The technique of felt deflection was standardised. 10 mm thick adhesive felt large enough to cover either the affected area was cut with an aperture 5 mm larger than the wound with all edges bevelled. In group1 the padding was adhered directly to the foot and in group 2 the padding was adhered to the shoe with the aperture directly over the ulcer.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-20 13:45:34 +0100" MODIFIED_BY="[Empty name]">
<P>Healed in 98 days (14 weeks, 3.5 months).Criteria for healing not stated.<BR/>Secondary outcomes: infection; amputation; compliance/concordance; admission to hospital.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:39:17 +0100" MODIFIED_BY="[Empty name]">
<P>Largest ulcer used as index ulcer. Funding: not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-09-22 20:18:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Piaggesi-1998">
<CHAR_METHODS MODIFIED="2009-11-04 14:46:16 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-09-22 20:12:17 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 43 patients with diabetes and 1 or more neuropathic foot ulcers.<BR/>24 ulcers in 21 patients in group 1 and 22 ulcers in 22 patients group 2.<BR/>Inclusion criteria: Type 1 or type 2 diabetes for <U>&gt;</U> 5 years; one or more painless, non-ischaemic,  non-complicated foot ulcers.<BR/>Exclusion criteria: symptomatic claudication or absence of foot pulses; recent ketoacidosis; renal failure; infection; congenital foot deformities; neuroarthropathy; BMI at or above 30; stroke, cardiac failure, cancer, HIV, MI, osteomyelitis; ABPI &lt; 0.9.<BR/>Baseline comparability: age, duration of diabetes, BMI, HbA1c, and VPT.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-18 10:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: saline-moistened sterile gauze dressing.<BR/>Group 2: surgical excision, debridement, closure (surgical debridement).</P>
<P>In group 1 patients were advised to change the dressings every 24 hours, helped by a trained relative if necessary. They were given special shoes with a custom-made orthosis to relieve pressure on the ulcer and advised to reduce weight-bearing by using crutches. They were seen twice weekly as outpatients for wound irrigation with povidone-iodine solution and inspection and control of orthosis. Group 2 received a day surgical procedure of conical ulcer removal and removal of underlying bone segments. A swab was taken to assess infection if necessary. The surgical wound was closed with a single stitch and a drain. Crutches and the same special shoes with a custom-made orthosis as group 1 were provided for the first week and 4-6 weeks after surgery they were allowed to walk with the special shoes alone.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-22 20:18:11 +0100" MODIFIED_BY="[Empty name]">
<P>Complete epithelialisation (group 1), formation of continuous scar (group 2) at 6 months. the difference in outcomes measures had the potential to produce bias.<BR/>Secondary outcomes: infection; amputation; concordance; admission to hospital.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:39:28 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: not stated<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-24 10:32:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Piaggesi-2007">
<CHAR_METHODS MODIFIED="2010-07-16 14:02:41 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-31 11:42:05 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 40 patients with diabetes and a neuropathic forefoot plantar ulcer.<BR/>20 patients both in group 1 and 2.<BR/>Inclusion criteria: Type 1 or 2 diabetes <U>&gt;</U> 5 years; peripheral neuropathy; ulcer for <U>&gt;</U> 3 weeks; Texas Wound Classification A1 or A2; insensitivity to a 10 g monofilament; VPT at malleolus <U>&gt;</U> 25 volts.<BR/>Exclusion criteria: peripheral vascular disease with ABPI &lt; 0.9; clinical signs of infection; previous ulcers at same site in last 6 months; osteomyelitis; Charcot&#8217;s neuropathy; bilateral ulceration; serum creatinine &gt; 2 mg/dl; systemic pathology or therapy interfering with healing process; severe visual or motor impairment putting patient at risk of accidents during the study and/or less than 1 year life expectancy.<BR/>Baseline comparability: age, duration of diabetes, neuropathy, area of lesion.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-24 10:32:03 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: total contact cast (TCC, non-removable cast);<BR/>Group 2: Optima Diab Walker (removable device).</P>
<P>Ulcers were surgically debrided in both groups removing all non-viable tissue, exposing the ulcer. Ulcers were dressed with gauze containing paraffin and covered with a single layer of sterile gauze. In group 1 the TCC was then applied with the ulcer protected by a layer of foam. In Group 2 the Optima Diab Walker was applied to each patient and individually adapted. Cotton wool was used to protect the limb and the three-layer insole adapted to accommodate the ulcer.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-09 22:04:28 +0100" MODIFIED_BY="[Empty name]">
<P>Complete re-epithelialisation at 12 weeks.<BR/>Secondary outcomes: infection; cost.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:39:53 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: Quote: "We acknowledge the generous contribution of Salvatelli srl, Cititanova marche, Italy, manufacturers of Optima Diab Molliter walkers used in this study".</P>
<P>Comment: It is possible that funding from the organisation which produces one of the pressure relieving devices could have influenced the outcomes. <BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-03 08:45:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-de-Weg-2008">
<CHAR_METHODS MODIFIED="2012-10-03 08:45:02 +0100" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-03 08:45:59 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 43 patients with diabetes and a neuropathic plantar foot ulcer.<BR/>23 patients in group 1 and 20 patients in group 2.<BR/>Inclusion criteria: sensory neuropathy threshold 10 g monofilament; Wagner Grade 1 or 2 ulcer.<BR/>Exclusion criteria: patients unable to walk indoors; dementia; life threatening co-morbidity; ABPI &lt; 0.4 and/or osteomyelitis.</P>
<P>Baseline comparability: imbalance for HbA1c and gender in both groups, but this would be unlikely to affect the results.</P>
<P>One participant crossed over from TCC to CTF group, but was analysed in TCC group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-27 10:27:14 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: total contact cast (TCC, non-removable cast);<BR/>Group 2: custom-made temporary footwear (temporary therapeutic shoe).</P>
<P>Group 1 patients had a TCC applied over a single layer of padding applied following debridement and application of a moisture retentive dressing. The cast was changed weekly. Group 2 patients received a custom-made shoe comprising a rigid leather socket with rubber to restrict movement and cork insoles to allow pressure relief for the ulcer. All patients were given instructions regarding routine care and advised to restrict their mobility to one third of that pretrial.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-07-18 11:04:02 +0100" MODIFIED_BY="[Empty name]">
<P>Complete re-epithelialisation at 16 weeks:<BR/>Secondary outcomes: amputation; concordance; mortality.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:35:01 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: Quote: "This study was supported by a grant from Convatec Netherlands and Ontwikkelingfonds Orthopedisch Maatschoeisel. Neither was involved in handling of data in any way".</P>
<P>Comment: It is possible that funding from the organisation which produces one of the pressure relieving devices could have influenced the outcomes.</P>
<P>
<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-06-14 15:35:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zimny-2002">
<CHAR_METHODS MODIFIED="2009-11-05 11:44:45 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-31 11:43:26 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 61 patients with diabetes and neuropathic plantar foot ulcer.<BR/>27 patients in group 1 and 34 patients in group 2.<BR/>Inclusion criteria: Type 1 and Type 2 diabetes mellitus; sensory neuropathy vibration perception Rydell-Seiffer tuning fork 3/8.<BR/>Exclusion criteria: peripheral vascular disease; media sclerosis; osteomyelitis.</P>
<P>Baseline comparability: Imbalance for type of diabetes, but this imbalance would be unlikely to make a difference to the results of the study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-27 10:27:30 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: felted foam dressing;<BR/>Group 2: temporary therapeutic half shoe.</P>
<P>All patients received repeated debridement as necessary and daily monitoring of the ulcer. Group 1 patient received the felted foam with an aperture to fit the ulcer. The pad was secured by gauze and the wound covered in a saline soaked sponge cut according to the size of the ulcer which was changed daily. The felted foam was changed every third day and kept dry at all times. Group 2 patients received a pressure relief half-shoe that transferred weight to their heel. All patients were asked to refrain from walking as far as possible.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-20 13:45:01 +0100" MODIFIED_BY="[Empty name]">
<P>Criteria for healing not stated. Healing at 10 weeks.<BR/>Secondary outcomes: infection, concordance.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-14 15:35:17 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>&gt; = greater/more than<BR/>
<U>&gt;</U> = greater/more than or equal to<BR/>&lt; = less/fewer than<BR/>ABPI = ankle brachial pressure index<BR/>ATL = Achilles tendon lengthening<BR/>BMI = body mass index<BR/>HbA1c = glycosylated haemoglobin level<BR/>HIV = human immunodeficiency virus<BR/>ITT = intention-to-treat<BR/>MI = myocardial infarction<BR/>TcPO<SUB>2</SUB> = transcutaneous pressure of oxygen<BR/>V = volts<BR/>VPT = vibration perception threshold</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-01-23 07:26:03 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:35 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Armstrong-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:35 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:36 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Birke-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:36 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:38 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Black-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:38 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:42 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Borssen-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:42 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:43 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Colagiuri-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:43 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Prevention not treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:44 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Guzman-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:44 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:45 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Ha-Van-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:45 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:47 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Hartsell-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:47 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:48 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Helm-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:48 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:52 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Lavery-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:52 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:53 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Lavery-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:53 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:55 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Lin-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:55 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:56 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Matricali-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:56 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:57 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Mueller-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:57 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:08:57 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Nabuurs_x002d_Franssen-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:08:57 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-19 10:33:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salsich-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-19 10:33:26 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome measure was muscle performance post tendo-Achiles lengthening. Ulcer healing was not measured and none of the secondary outcomes were measured.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:09:01 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Samanta-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:09:01 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:09:08 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Tyrrell-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:09:08 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Prevention of DFU, unable to extract data on healing.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 12:09:09 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Uccioli-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 12:09:09 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Prevention of DFU.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>DFU = diabetic foot ulcer(s)<BR/>RCT = randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-11-09 17:58:13 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2012-10-03 08:49:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gutekunst-2011">
<CHAR_METHODS MODIFIED="2012-09-23 06:34:00 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-03 08:46:31 +0100" MODIFIED_BY="[Empty name]">
<P>Number: 23 patients with diabetes and neuropathic plantar foot ulcer.<BR/>11 patients in group 1 and 12 patients in group 2.<BR/>Inclusion criteria: Type 1 and Type 2 diabetes mellitus; peripheral neuropathy, defined as loss of protective sensation; one or more plantar ulceration.<BR/>Exclusion criteria: infection; lower extremity ischaemia or cellulitis.</P>
<P>Baseline comparability: sex, type of diabetes, age, height, weight, BMI, HbA1c, Diabetes duration, walking speed.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-03 08:49:00 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: total contact cast (TCC, non-removable cast);<BR/>Group 2: removable cast walker boot (RCW).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-03 08:46:27 +0100" MODIFIED_BY="[Empty name]">
<P>Criteria for healing not stated. Healing at 94 days.<BR/>Secondary outcomes: none stated.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-03 08:46:28 +0100" MODIFIED_BY="[Empty name]">
<P>Funding: National Institutes of Health.</P>
<P>Quote: Authors declare "no financial or personal relationships with people or organisations that could inappropriately influence the submitted work".</P>
<P>Comment: It is unlikely that funding from this organisation would have influenced the outcomes.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2012-11-09 17:58:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vallini-2012">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES MODIFIED="2012-11-09 17:58:13 +0000" MODIFIED_BY="[Empty name]">
<P>Conference abstract only; awaiting full publication</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2009-11-26 14:16:16 +0000" MODIFIED_BY="Elizabeth Royle" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2009-11-26 14:16:16 +0000" MODIFIED_BY="Elizabeth Royle" STUDY_ID="STD-Agas-2006">
<CHAR_STUDY_NAME MODIFIED="2009-11-05 12:11:56 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Effect of Window Casts on healing rates of diabetic foot ulcers.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2009-11-05 12:12:26 +0000" MODIFIED_BY="Elizabeth Royle">
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-05 12:12:04 +0000" MODIFIED_BY="Elizabeth Royle">
<P>20 participants with 23 ulcers.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-26 14:16:16 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Group 1: Window casts with topical platelet-derived growth factor;<BR/>Group 2: Window casts with hydrogel, pressure-relieving shoes with platelet-derived growth factor;<BR/>Group 3: pressure-relieving shoes with hydrogel.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-05 12:13:27 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Ulcer healing.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2009-11-05 12:13:29 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Starting date 2001, estimated end date not known.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2009-07-31 13:26:42 +0100" MODIFIED_BY="[Empty name]">
<P>Ian.Gordon@med.va.gov</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2009-11-05 12:12:20 +0000" MODIFIED_BY="Elizabeth Royle">
<P>Stated as an ongoing study by the contact author.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Quote: "Patients were randomised through a computerised randomisation schedule".</P>
<P>Comment: Investigators described random sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 14:52:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: "Patients were randomly assigned through a computerized randomization schedule".</P>
<P>Comment: Investigators described random sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-29 08:26:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Table of random numbers was consulted remotely.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 13:03:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Quote: "We used tables for randomisation".</P>
<P>Comment: information provided by the author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-31 11:21:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Quote: "Patients were randomly assigned to one of the two treatment groups by opening randomization codebreak envelopes containing one of the two options".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 13:21:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Quote: "The selected patients were randomly allocated".</P>
<P>Comment: We were unable to contact author for further information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-14 15:24:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Quote: "using a pre prepared random number table".</P>
<P>Comment: Investigators described random sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 14:10:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Quote "A randomized list was generated at start of study.</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 16:04:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Quote: "The patient coordinator for the study assigned the subject to a treatment group according to the prearranged schedule generated by a computer program".</P>
<P>Comment: Deemd to be low risk for selection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 14:49:36 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Quote: "All ulcers were randomly assigned by drawing lots".</P>
<P>Comment: The lots were in unsealed envelopes (information provided by author).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:01:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Quote: "Patients were randomised into two groups according to a table of randomisation".</P>
<P>Comment: Deemed as low risk of selection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:16:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Quote: "Participants were then randomly divided into two different groups with a computer generated randomisation list".</P>
<P>Comment: The study is at low risk for selection bias regarding sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:24:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Quote: "An independent person prepared a randomisation list in advance with an equal number of treatment assignments (5/5) blocks of ten to ensure approximately equal number of patients in each treatment group".</P>
<P>Comment: The study is at low risk for selection bias regarding sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 16:08:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Quote: "the  allocation for the treatment were generated using a computer (1 = felted foam, 2 = conventional treatment)".</P>
<P>Comment: Stated in correspondence with the author, reducing the risk of selection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-09-14 12:28:49 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 14:37:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Not described. </P>
<P>Comment: The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:03:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: "Randomization was performed after the initial screening, with allocation provided to the treating clinician by a single study co-ordinator via telephone".</P>
<P>Comment: Investigators described allocation concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:03:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Quote: "The randomization required that a patient was assigned to the shoe or cast group by calling the Biometrics Institute, University of Milan, Italy where a table of random numbers was consulted".</P>
<P>Comment: Investigators described allocation concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-26 14:04:00 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Unclear, despite contact with author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-14 12:28:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Quote: Separate randomization was performed for each center, and a copy of all randomization envelopes was kept at the statistical department of the Multimedica center".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 13:46:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Not stated (unable to contact author).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-23 09:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Not stated despite contact with the author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 14:10:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Quote: "Each new subject that agreed to participate took the next &#8220;assignment&#8221; from the concealed list". </P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 16:04:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Quote: "Patient co-ordinator for the study who assigned the subject to a prearranged schedule".</P>
<P>Comment: deemed to be low risk for selection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:54:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Quote: "an independent person (not working in the foot clinic) was asked to draw one piece of paper out of the appropriate envelope".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:02:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Allocation concealment not stated therefore insufficient information about sequence generation. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-18 11:01:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Unclear, no response from contact with author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Quote: "Allocation was concealed using opaque, sealed envelopes".</P>
<P>Comment: The study is at low risk for selection bias regarding allocation concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 16:08:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Quote: "Randomisation was done with sealed envelopes" </P>
<P>Comment: Stated in correspondence with the author, reducing the risk of selection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-09-22 18:11:32 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>Blinding care provider</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Blinding patient</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.03" NO="3">
<NAME>Blinding outcome assessor</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-13 09:13:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Quote: "Without physically blinding the patient we were unaware of a method of blinding them to the device!"</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-13 09:14:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Quote: " The care provider and outcomes assessor were blinded to treatment".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-13 09:14:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Quote: " The care provider and outcomes assessor were blinded to treatment".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-13 09:22:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: "Without physically blinding the patient we were unaware of a method of blinding them to the device!"</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-13 09:22:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: " The care provider and outcomes assessor were blinded to treatment".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-13 09:22:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: " The care provider and outcomes assessor were blinded to treatment".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-22 15:04:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Quote: "No blinding of participant".</P>
<P>Comment: Information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2012-09-22 18:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Quote: "No blinding of participant" (patient).</P>
<P>Comment: Information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-09-16 10:01:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Quote: "No blinding of participant".</P>
<P>Comment: Information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-21 13:04:39 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Quote: "There was no blinding of participants". </P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-21 13:04:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Quote: "No blinding of care provider"</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-21 13:05:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Quote: "No blinding of outcome assessor".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-09-14 12:29:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Not reported despite contact with the author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-09-14 12:30:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Not reported despite contact with the author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-09-14 12:30:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Not reported despite contact with the author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-04 11:50:33 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2009-11-04 11:50:34 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2009-11-04 11:50:34 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-23 09:25:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-08-31 11:28:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-01-23 09:25:44 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-21 14:11:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Quote: "No &#8211; not possible".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-21 14:12:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Quote: "No &#8211; not possible".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-21 14:12:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Quote: "No".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-21 14:38:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Quote: "No &#8211; not possible".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-21 14:38:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Quote: "No &#8211; not possible".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-21 14:38:00 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Quote: "No".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-21 14:53:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Quote: " Neither the patient or the assessor was blinded".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-08-31 11:28:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-21 14:53:54 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Quote: " Neither the patient or the assessor was blinded".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-04 14:49:59 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-21 15:07:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Quote: "From initial debridement to follow up visits was performed by physicians and nurses unaware of the participation of patients in the study".</P>
<P>Comment: This reduces the risk of performance and detection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2009-11-04 14:50:00 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-07-18 11:01:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Unclear, no response from contact with author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-18 11:01:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Unclear, no response from contact with author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2010-07-18 11:01:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Unclear, no response from contact with author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-05 11:32:47 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Blinding of participants not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2011-06-21 15:25:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Quote: "Wound care and wound debridement was carried out by a podiatrist blinded to treatment mode".</P>
<P>Comment: The study is at low risk for selection bias regarding performance and detection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-21 15:25:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Quote: "Wound measurement was undertaken by a research assistant blinded for the treatment".</P>
<P>Comment: The study is at low risk for selection bias regarding performance and detection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-21 15:40:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Quote: "Patients were not blinded".</P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2009-11-05 11:48:44 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="UNKNOWN" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Not stated, despite contact with author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2011-06-22 16:09:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Quote: "Dressings were removed before the investigators assessed the foot ulcers" </P>
<P>Comment: information provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-10-03 08:43:59 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>ITT analysis</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Drop outs / withdrawals</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-06-22 15:11:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Quote: "12 failed to complete the course of study".<BR/>Comment: This is 16% drop out rate and judged as high risk for attrition bias as reasons for this included discomfort (four TCC and three RCW), instability (one half-shoe), failure to attend follow up appointment (two TCC, two RCW).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-06-22 14:41:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>ITT was not reported as performed.</P>
<P>Comment: The study did not address this outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-09-19 11:28:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: "4 failed to complete the course of study".</P>
<P>Comment: "Reasons for this included discomfort/weight of the device (one RCW, one iTCC) or failure to attend follow up appointment (two RCW)'. ITT methods could not be confirmed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-09-22 19:45:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Quote: The drop out "patients were considered treatment failures for the purposes of the intention to treat analysis".</P>
<P>Comment: Judged as high risk as drop outs should not be considered as treatment failures.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-26 14:14:38 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="YES" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>No dropouts reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-08-10 08:17:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Not stated as performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-06-22 15:10:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Quote " Six patients in group A (APW) and five patients in group B (TCC) did not finish the study when occurrence of serious infection of the ulcer required antibiotic therapy and surgical debridement".</P>
<P>Comment: This is a 19% drop out rate and deemed high risk for attrition bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-09-22 19:47:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>No ITT reported. Analysis performed on all 58 patients, but drop outs were assumed to be failures even though they should not be considered as such. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-08-31 11:34:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Three dropouts reported. </P>
<P>Quote: "one patient in the TCC group withdrew consent, one patient in the TCC group stopped treatment ... and one patient in the Stabil-D group was unable to complete off-loading treatment because of ulcer infection".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-08-31 11:34:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>ITT analysis not stated as performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-06-21 13:52:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Three patients lost to follow-up in the dressing group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-06-22 15:31:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Intention to treat analysis not reported. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-09-14 10:01:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Quote: "Four patient were lost to follow up (in TCC group)... with 2 being lost to follow up and one patient was found to have osteomyelitis before study entry (in the iTCC group).</P>
<P>Comment: The drop out rate was 17% and this was deemed high risk for attrition bias. ITT methods could not be confirmed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-09-22 20:05:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Quote "All parameters were analysed as intention to treat".</P>
<P>Comment: Despite this claim the study is deemed high risk as drop outs should not be considered as treatment failures.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-06-22 15:45:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>No dropouts reported however information provided by the author states: "The one subject died and was not included in wound healing descriptive summary.  All other subjects were included in results of primary variable analysis".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-09-14 09:56:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Quote: "The one subject died and was not included in wound healing descriptive summary.  All other subjects were included in results of primary variable analysis".</P>
<P>Comment: ITT not stated in the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-26 14:07:27 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="YES" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>One dropout reported at 7 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-08-09 11:51:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>ITT analysis not stated as performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-03 08:43:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>6 dropouts reported: In the felt-to-foot group 2 failed to attend appointments and the GP removed felt from one ulcer erroneously. In the felt-to-shoe group one person failed to wear the shoe and another dropped out for an unrelated medical reason.</P>
<P>Comment: A 15% drop out rate makes the study at high risk of attrition bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-06-21 14:59:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>ITT analysis not stated as performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-06-21 15:16:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>No drop outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-08-10 08:23:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>ITT analysis not stated. Assessed as low risk as all participants were accounted for and included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-09-14 10:01:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Quote: "All patients of both groups completed the study and attended all control visits".</P>
<P>Comment: No dropouts reported. ITT methods could not be confirmed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-08-10 08:24:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Quote: " The data ... were analysed according to the intention-to-treat model" but no detail on the method was given. Assessed as low risk as all participants were accounted for and included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-23 06:33:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>2 dropouts reported in the TCC group but no reason stated.</P>
<P>1 participant crossed over to group 2, but was analysed in group 1.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-06-14 15:24:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Quote: "The analysis of effectiveness was done according to the intention-to-treat principle".</P>
<P>Comment: Prisma diagram (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) does not support this statement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-26 14:13:13 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>No dropouts reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-08-10 08:25:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>ITT analysis not stated. Assessed as low risk as all participants were accounted for and included in the final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-09-22 18:17:54 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:17:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 12:49:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:17:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:16:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:16:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:15:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:15:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Prespecifed outcomes reported on, but the trial protocol was not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:15:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:15:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:14:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:14:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:13:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:13:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not accessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-03 09:55:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Prespecified outcomes reported on, but the trial protocol not assessed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-07-21 17:43:16 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2012-09-22 20:17:32 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Timing of outcome assessment similar in all groups?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-04 11:51:52 +0000" MODIFIED_BY="Elizabeth Royle" RESULT="YES" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>Length of follow-up: 12 weeks for all groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-21 09:13:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Length of follow-up 12 weeks or until healed - similar in both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:06:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Yes, 30 days in both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:17:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Yes, 90 days for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-31 11:35:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>90 days for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:24:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Yes, six months after complete epithelialisation in both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:28:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Yes, when healed or at 12 weeks for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:48:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Yes, 13.1 weeks for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 14:38:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Yes, 7 months and 2 years for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-31 11:41:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Yes, 4, 8 and 14 weeks for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 20:17:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Outcomes were assessed at 6 months for both groups, but group 1 had to epithelialize and group 2 had to develop a continuous scar.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:18:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Yes, 12 weeks for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:29:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Yes, 2, 4, 8 and 16 weeks for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:30:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Yes, 10 weeks for both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2012-09-22 20:28:38 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Baseline imbalance? (were groups balanced at baseline)</NAME>
<DESCRIPTION>
<P>Group balanced at baseline</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:10:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2001">
<DESCRIPTION>
<P>All groups similar at baseline for gender, duration of diabetes, TcPO<SUB>2</SUB>, wound size and duration and VPT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-13 09:24:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armstrong-2005">
<DESCRIPTION>
<P>Both groups similar at baseline for age, gender, BMI, wound size, VPT and HbA<SUB>1c</SUB>.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:11:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2000">
<DESCRIPTION>
<P>Both groups similar at baseline for age, sex, diabetes treatment, prior lesions, BMI, smoking, hypertension, retinopathy, renal impairment, and TcPO<SUB>2</SUB>.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 13:18:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caravaggi-2007">
<DESCRIPTION>
<P>Quote: "Clinical characteristics (age, sex, type of diabetes, and duration of diabetes) of both groups were comparable".</P>
<P>Comment: Deemed as low risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-31 11:37:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faglia-2010">
<DESCRIPTION>
<P>Baseline comparability for age, sex, duration of diabetes, BMI, HbA1c, previous foot ulcer, minor amputation and mean area of ulcer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:35:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ganguly-2008">
<DESCRIPTION>
<P>Both groups similar at baseline for age and gender.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 20:05:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Katz-2005">
<DESCRIPTION>
<P>Both groups similar at baseline for age, gender, ethnicity, diabetes type and duration, smoker, VPT, neuropathy disability score, ulcer area, duration and distribution.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:49:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-1989">
<DESCRIPTION>
<P>Both groups similar at baseline for age, gender, type of diabetes, ulcer duration, size, sensation and vascular disease.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 15:50:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mueller-2003">
<DESCRIPTION>
<P>Both groups similar at baseline for age, gender, duration of diabetes, body mass index, HbA1c, number of previous ulcers and ulcer size. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-14 10:56:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nube-2006">
<DESCRIPTION>
<P>Imbalance for ulcer duration and HbA1c.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-21 15:10:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-1998">
<DESCRIPTION>
<P>Both groups were similar at baseline for type of diabetes, age, duration of diabetes, body mass index, HbA1c, VPT at first toe and malleolus.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 18:13:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piaggesi-2007">
<DESCRIPTION>
<P>Both groups similar at baseline for age, duration of diabetes, HbA1c, VPT and area of ulcer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-22 20:28:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-de-Weg-2008">
<DESCRIPTION>
<P>Baseline imbalance for HbA1c and gender in both groups, but this would be unlikely to affect the results as the differences were small.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-31 11:43:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimny-2002">
<DESCRIPTION>
<P>Imbalance for type of diabetes, but this imbalance would be unlikely to make a difference to the results of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2012-06-14 15:40:06 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Free of commercial sponsorship?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" NO="10">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="GROUP" NO="11">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2011-09-16 10:21:15 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Non-removable pressure relieving device versus another non-removable instant pressure relieving cast</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-09-16 10:20:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Skin maceration</NAME>
<GROUP_LABEL_1>TCC (non-removable)</GROUP_LABEL_1>
<GROUP_LABEL_2>iTCC (non-removable)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours instant non-rem</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-removable</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.01974776599746" CI_START="0.49693720015198856" EFFECT_SIZE="1.225" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.47997066864909693" LOG_CI_START="-0.30369849124799436" LOG_EFFECT_SIZE="0.0881360887005513" MODIFIED="2011-06-13 12:05:23 +0100" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.4603311437484563" STUDY_ID="STD-Katz-2005" TOTAL_1="20" TOTAL_2="21" VAR="0.21190476190476193" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="15.67561456624075" CI_START="0.0703321707318807" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="1.1952245764561868" LOG_CI_START="-1.1528459783163107" LOG_EFFECT_SIZE="0.021189299069938092" METHOD="MH" MODIFIED="2011-09-16 10:21:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.971781558064997" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="21" WEIGHT="100.0" Z="0.03537394815527642">
<NAME>Toe amputation</NAME>
<GROUP_LABEL_1>TCC (non-removable)</GROUP_LABEL_1>
<GROUP_LABEL_2>iTCC (non-removable)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours instant non-rem</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-removable</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.67561456624075" CI_START="0.0703321707318807" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1952245764561868" LOG_CI_START="-1.1528459783163107" LOG_EFFECT_SIZE="0.021189299069938092" MODIFIED="2011-06-13 12:11:32 +0100" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="1.3792682670100667" STUDY_ID="STD-Katz-2005" TOTAL_1="20" TOTAL_2="21" VAR="1.9023809523809523" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2011-08-24 12:58:41 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Removable pressure relieving device versus another removable pressure-relieving device</NAME>
<DICH_OUTCOME CHI2="3.966638018328413" CI_END="1.2951350430585986" CI_START="0.7280270778907496" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9710269722679498" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="43" I2="49.57946778206843" I2_Q="47.27395743912614" ID="CMP-002.01" LOG_CI_END="0.11231505443846017" LOG_CI_START="-0.1378524674454276" LOG_EFFECT_SIZE="-0.012768706503483726" METHOD="MH" MODIFIED="2011-08-24 12:58:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1376119327076103" P_Q="0.15007873671468897" P_Z="0.8414214788182556" Q="3.7931919462586974" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="67" TOTAL_2="76" WEIGHT="300.0" Z="0.20007557086172104">
<NAME>Diabetic foot ulcers healed</NAME>
<GROUP_LABEL_1>Removable</GROUP_LABEL_1>
<GROUP_LABEL_2>Another removable</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours removable</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours another removable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.550082129088543" CI_START="0.5562575567955155" DF="0" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.19035470930901688" LOG_CI_START="-0.25472407605181935" LOG_EFFECT_SIZE="-0.03218468337140124" MODIFIED="2011-06-17 16:18:30 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7768249154530719" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.28345911931358597">
<NAME>RCW verus removable half shoe (healing at 12 weeks)</NAME>
<DICH_DATA CI_END="1.550082129088543" CI_START="0.5562575567955155" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.19035470930901688" LOG_CI_START="-0.25472407605181935" LOG_EFFECT_SIZE="-0.03218468337140124" MODIFIED="2011-06-17 16:18:30 +0100" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.26144148169647513" STUDY_ID="STD-Armstrong-2001" TOTAL_1="25" TOTAL_2="25" VAR="0.06835164835164834" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.064507502134692" CI_START="0.4343792778094416" DF="0" EFFECT_SIZE="0.68" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.02714872648286019" LOG_CI_START="-0.3621309010703875" LOG_EFFECT_SIZE="-0.16749108729376366" MODIFIED="2011-06-17 16:43:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.09168326867884152" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="17" WEIGHT="100.0" Z="1.6865845299460358">
<NAME>Felt fitted to foot versus felt fitted to temporary therapeutic footwear (healing at 98 days)</NAME>
<DICH_DATA CI_END="1.064507502134692" CI_START="0.4343792778094416" EFFECT_SIZE="0.68" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.02714872648286019" LOG_CI_START="-0.3621309010703875" LOG_EFFECT_SIZE="-0.16749108729376366" MODIFIED="2011-06-17 16:19:45 +0100" MODIFIED_BY="[Empty name]" ORDER="33" O_E="0.0" SE="0.22866478019001174" STUDY_ID="STD-Nube-2006" TOTAL_1="15" TOTAL_2="17" VAR="0.052287581699346386" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2799127807800663" CI_START="0.7984330751968042" DF="0" EFFECT_SIZE="1.3492063492063493" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="0.3579182331625324" LOG_CI_START="-0.09776148064111025" LOG_EFFECT_SIZE="0.13007837626071106" MODIFIED="2011-06-17 16:43:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.2631473983973519" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="34" WEIGHT="100.0" Z="1.1189830265224576">
<NAME>Felted foam dressing versus temporary therapeutic footwear (healing at 10 weeks)</NAME>
<DICH_DATA CI_END="2.2799127807800663" CI_START="0.7984330751968041" EFFECT_SIZE="1.3492063492063493" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.3579182331625324" LOG_CI_START="-0.09776148064111032" LOG_EFFECT_SIZE="0.13007837626071106" MODIFIED="2011-06-17 16:04:17 +0100" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.2676685195392217" STUDY_ID="STD-Zimny-2002" TOTAL_1="27" TOTAL_2="34" VAR="0.07164643635231871" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Non-removable pressure relieving device versus removable pressure relieving device</NAME>
<DICH_OUTCOME CHI2="9.466678634325865" CI_END="1.4395085887651127" CI_START="1.0699908841097452" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="1.241072547265612" ESTIMABLE="YES" EVENTS_1="134" EVENTS_2="120" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.15821426042088593" LOG_CI_START="0.029380077687359445" LOG_EFFECT_SIZE="0.09379716905412268" METHOD="MH" MODIFIED="2012-09-22 19:14:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4884591406550477" P_Q="0.6347961934736256" P_Z="0.00431879458426667" Q="0.9089026685471061" RANDOM="NO" SCALE="105.86" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="248" TOTAL_2="266" WEIGHT="300.0" Z="2.853886589681529">
<NAME>Diabetic foot ulcers healed</NAME>
<GROUP_LABEL_1>Non-removable</GROUP_LABEL_1>
<GROUP_LABEL_2>Removable device</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours removable</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-removable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.9129617652906927" CI_END="1.3574231318287113" CI_START="1.0102643246248368" DF="4" EFFECT_SIZE="1.1710491721132226" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="83" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.13271524572473337" LOG_CI_START="0.00443501705719194" LOG_EFFECT_SIZE="0.06857513139096266" MODIFIED="2011-08-31 09:00:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4179134920665962" P_Z="0.03612770627911233" STUDIES="5" TAU2="0.0" TOTAL_1="107" TOTAL_2="123" WEIGHT="100.0" Z="2.0954871870351943">
<NAME>Non-removable device versus removable device (healing at 12 weeks)</NAME>
<DICH_DATA CI_END="2.2209054298263338" CI_START="0.7400835117674794" EFFECT_SIZE="1.2820512820512822" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="0.3465300658969617" LOG_CI_START="-0.13071927127792238" LOG_EFFECT_SIZE="0.10790539730951963" MODIFIED="2011-08-17 11:05:54 +0100" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.28033862307884655" STUDY_ID="STD-Armstrong-2001" TOTAL_1="12" TOTAL_2="25" VAR="0.0785897435897436" WEIGHT="10.857024432944728"/>
<DICH_DATA CI_END="2.398198644605636" CI_START="1.058370761725597" EFFECT_SIZE="1.593167701863354" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="14" LOG_CI_END="0.3798851531928022" LOG_CI_START="0.024637833639168615" LOG_EFFECT_SIZE="0.2022614934159854" MODIFIED="2011-08-17 11:01:56 +0100" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.2086740340083969" STUDY_ID="STD-Armstrong-2005" TOTAL_1="23" TOTAL_2="27" VAR="0.04354485246933759" WEIGHT="16.583408858218398"/>
<DICH_DATA CI_END="1.338920540689104" CI_START="0.8132274080633448" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" LOG_CI_END="0.12675480422320234" LOG_CI_START="-0.08978799283517609" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2011-08-17 11:02:04 +0100" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.1271983108962244" STUDY_ID="STD-Caravaggi-2007" TOTAL_1="29" TOTAL_2="29" VAR="0.016179410294852564" WEIGHT="29.613230103961424"/>
<DICH_DATA CI_END="1.446165927036303" CI_START="0.7142157812602645" EFFECT_SIZE="1.016304347826087" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.16021812495167007" LOG_CI_START="-0.1461705578977451" LOG_EFFECT_SIZE="0.007023783526962488" MODIFIED="2011-08-31 09:00:13 +0100" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.17997422895418674" STUDY_ID="STD-Faglia-2010" TOTAL_1="23" TOTAL_2="22" VAR="0.03239072308765403" WEIGHT="21.05829696281701"/>
<DICH_DATA CI_END="1.3785024360948266" CI_START="0.9061536021913553" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.13940753792935562" LOG_CI_START="-0.04279817878024559" LOG_EFFECT_SIZE="0.048304679574555046" MODIFIED="2011-08-17 11:02:01 +0100" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.10702853992806366" STUDY_ID="STD-Piaggesi-2007" TOTAL_1="20" TOTAL_2="20" VAR="0.011455108359133118" WEIGHT="21.888039642058445"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0398176758693076" CI_END="2.438097042882533" CI_START="0.7812478476242425" DF="2" EFFECT_SIZE="1.3801297283411473" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="0.3870509877260196" LOG_CI_START="-0.1072111661486071" LOG_EFFECT_SIZE="0.13991991078870622" MODIFIED="2011-08-31 10:09:36 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5945748316808248" P_Z="0.26713421920642333" STUDIES="3" TAU2="0.0" TOTAL_1="79" TOTAL_2="74" WEIGHT="100.00000000000001" Z="1.1096863626563815">
<NAME>Skin maceration</NAME>
<DICH_DATA CI_END="2.616233351152802" CI_START="0.7704583482624856" EFFECT_SIZE="1.4197530864197532" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="9" LOG_CI_END="0.4176764776485205" LOG_CI_START="-0.11325083469859652" LOG_EFFECT_SIZE="0.15221282147496196" MODIFIED="2011-08-19 08:27:33 +0100" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.3118693314052786" STUDY_ID="STD-Armstrong-2005" TOTAL_1="27" TOTAL_2="23" VAR="0.0972624798711755" WEIGHT="73.3478903089076"/>
<DICH_DATA CI_END="7.447844832813669" CI_START="0.01370124584723243" EFFECT_SIZE="0.3194444444444444" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8720306200470282" LOG_CI_START="-1.8632399408743792" LOG_EFFECT_SIZE="-0.4956046604136756" MODIFIED="2011-08-31 09:48:47 +0100" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="1.6067114672928786" STUDY_ID="STD-Faglia-2010" TOTAL_1="23" TOTAL_2="22" VAR="2.5815217391304346" WEIGHT="11.559951191317193"/>
<DICH_DATA CI_END="10.080509445693664" CI_START="0.3968053421852381" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0034824809054168" LOG_CI_START="-0.4014224895774544" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2011-08-19 08:28:33 +0100" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.8252481340534014" STUDY_ID="STD-Piaggesi-2007" TOTAL_1="29" TOTAL_2="29" VAR="0.6810344827586208" WEIGHT="15.092158499775223"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6763967550276" CI_END="2.142374752788898" CI_START="0.9289176218759791" DF="2" EFFECT_SIZE="1.4107053769401328" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="25" I2="25.27266384391595" ID="CMP-003.01.03" LOG_CI_END="0.33089544167452795" LOG_CI_START="-0.032022798332517366" LOG_EFFECT_SIZE="0.1494363216710053" MODIFIED="2012-09-22 19:14:16 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.26231802290626505" P_Z="0.10650974974934972" STUDIES="3" TAU2="0.0" TOTAL_1="62" TOTAL_2="69" WEIGHT="100.0" Z="1.614081499191812">
<NAME>Non-removable device versus temporary therapeutic footwear (healing at 12 weeks, 30 days and 16 weeks respectively)</NAME>
<DICH_DATA CI_END="2.04245591373318" CI_START="0.7482893585728733" EFFECT_SIZE="1.2362637362637363" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" LOG_CI_END="0.3101526910898665" LOG_CI_START="-0.12593043083729102" LOG_EFFECT_SIZE="0.0921111301262877" MODIFIED="2012-09-22 19:14:16 +0100" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.25615738446628" STUDY_ID="STD-Armstrong-2001" TOTAL_1="13" TOTAL_2="25" VAR="0.0656166056166056" WEIGHT="45.18893200295639"/>
<DICH_DATA CI_END="5.725555032733057" CI_START="1.0060160049235436" EFFECT_SIZE="2.4" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.7578175933646486" LOG_CI_START="0.002604890058563358" LOG_EFFECT_SIZE="0.38021124171160603" MODIFIED="2011-06-17 16:08:24 +0100" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.44361568028516735" STUDY_ID="STD-Caravaggi-2000" TOTAL_1="26" TOTAL_2="24" VAR="0.19679487179487182" WEIGHT="24.53113451589061"/>
<DICH_DATA CI_END="2.2707960185558975" CI_START="0.3329861692190444" EFFECT_SIZE="0.8695652173913043" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.3561781240945415" LOG_CI_START="-0.4775738048017649" LOG_EFFECT_SIZE="-0.0606978403536117" MODIFIED="2011-06-17 16:08:35 +0100" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.48975001017230013" STUDY_ID="STD-Van-de-Weg-2008" TOTAL_1="23" TOTAL_2="20" VAR="0.23985507246376808" WEIGHT="30.279933481152987"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="15.658894205160628" CI_START="-18.458894205160625" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2012-10-24 08:28:52 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.8722103226507166" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.0" Z="0.16085155024444542">
<NAME>Time to healing</NAME>
<GROUP_LABEL_1>Non-removable device</GROUP_LABEL_1>
<GROUP_LABEL_2>Removable device</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours non-removable</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours removable</GRAPH_LABEL_2>
<CONT_DATA CI_END="15.658894205160628" CI_START="-18.458894205160625" EFFECT_SIZE="-1.3999999999999986" ESTIMABLE="YES" MEAN_1="45.5" MEAN_2="46.9" MODIFIED="2011-06-17 16:21:15 +0100" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="30.8" SD_2="23.8" SE="8.70367738372695" STUDY_ID="STD-Piaggesi-2007" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2011-09-16 11:02:15 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Non-removable device versus no pressure relief</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="55" EVENTS_2="31" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-09-16 11:02:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="60" TOTAL_2="55" WEIGHT="0.0" Z="0.0">
<NAME>Diabetic foot ulcers healed</NAME>
<GROUP_LABEL_1>Non removable cast</GROUP_LABEL_1>
<GROUP_LABEL_2>Traditional dressing</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dressing</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-removable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="55" EVENTS_2="31" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2011-09-16 11:02:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="55" WEIGHT="0.0" Z="0.0">
<NAME>Non-removable pressure relieving cast compared with dressing (healing at 6 months and 92 days respectively)</NAME>
<DICH_DATA CI_END="1.6811209591661815" CI_START="1.0509978049087936" EFFECT_SIZE="1.3292307692307692" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="25" LOG_CI_END="0.22559896270091573" LOG_CI_START="0.02160180897115967" LOG_EFFECT_SIZE="0.1236003858360377" MODIFIED="2011-09-16 11:02:15 +0100" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.1198289379030556" STUDY_ID="STD-Ganguly-2008" TOTAL_1="39" TOTAL_2="36" VAR="0.014358974358974354" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.634158901145557" CI_START="1.4569485724895976" EFFECT_SIZE="2.865079365079365" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="6" LOG_CI_END="0.7508290913039124" LOG_CI_START="0.1634442222722777" LOG_EFFECT_SIZE="0.457136656788095" MODIFIED="2011-06-17 16:13:51 +0100" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.3450327796711771" STUDY_ID="STD-Mueller-1989" TOTAL_1="21" TOTAL_2="19" VAR="0.11904761904761904" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2011-06-17 17:02:21 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Surgical intervention</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="60" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-06-17 17:02:21 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="888.27" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="84" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>Diabetic foot ulcers healed (healing at 7 months, 2 years and 6 months respectively)</NAME>
<GROUP_LABEL_1>Surgical intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure relieving device</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours pressure relief</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgery</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.183008085851341" CI_START="1.4180497525249292" EFFECT_SIZE="3.4064516129032256" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" LOG_CI_END="0.9129129803144184" LOG_CI_START="0.1516914684126232" LOG_EFFECT_SIZE="0.5323022243635207" MODIFIED="2011-06-17 16:51:59 +0100" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.4471452841983696" STUDY_ID="STD-Mueller-2003" TOTAL_1="31" TOTAL_2="33" VAR="0.19993890518084068" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.763682629475721" CI_START="1.316320967459401" EFFECT_SIZE="2.225806451612903" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="11" LOG_CI_END="0.5756129946493304" LOG_CI_START="0.11936179915663488" LOG_EFFECT_SIZE="0.3474873969029826" MODIFIED="2011-06-17 16:39:51 +0100" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.2680042107122513" STUDY_ID="STD-Mueller-2003" TOTAL_1="31" TOTAL_2="33" VAR="0.07182625695949679" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.5093433314876932" CI_START="0.9632088606052975" EFFECT_SIZE="1.2057416267942584" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="19" LOG_CI_END="0.17878804031272977" LOG_CI_START="-0.01627953097174952" LOG_EFFECT_SIZE="0.08125425467049012" MODIFIED="2011-06-17 16:38:12 +0100" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.11458365697255396" STUDY_ID="STD-Piaggesi-1998" TOTAL_1="22" TOTAL_2="24" VAR="0.013129414445203914" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-10-03 08:44:00 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-10-03 08:44:00 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-10-03 08:44:00 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-10-24 10:34:41 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-03-24 09:46:05 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-03-24 09:45:42 +0000" MODIFIED_BY="[Empty name]">Search methods for original review - 2000</TITLE>
<APPENDIX_BODY MODIFIED="2010-03-24 09:45:45 +0000" MODIFIED_BY="[Empty name]">
<P>RCTs of pressure relieving interventions for diabetic foot ulcers were identified from the Wounds Group Trials Register. Citations within identified studies were searched. In addition we wrote to manufacturers and distributors of pressure relieving products for details of unpublished and ongoing trials. We also contacted experts in the field of the management in the diabetic foot who have developed many of the interventions of interest for details of unpublished and ongoing trials.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2010-06-04 12:05:23 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2009-09-15 13:58:39 +0100" MODIFIED_BY="[Empty name]">Ovid MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-12-21 14:02:34 +0000" MODIFIED_BY="[Empty name]">
<P>1 pressure relie$.mp.<BR/>2 pressure reduc$.mp.<BR/>3 (pressure adj (distribut$ or redistribut$)).mp.<BR/>4 (alternat$ adj pressure).mp.<BR/>5 constant pressure.mp.<BR/>6 exp Bed Rest/<BR/>7 bed rest.mp.<BR/>8 exp Bony Callus/<BR/>9 callus.mp.<BR/>10 hosiery.mp.<BR/>11 stocking$.mp.<BR/>12 exp Shoes/<BR/>13 (shoe$ or boot$ or footwear).mp.<BR/>14 exp Orthotic Devices/<BR/>15 (orthoses or orthosis).mp.<BR/>16 orthotic$.mp.<BR/>17 insole$.mp.<BR/>18 foot insert$.mp.<BR/>19 cushion$.mp.<BR/>20 (heel adj elevat$).mp.<BR/>21 (elevat$ adj device$).mp.<BR/>22 (foot adj elevat$).mp.<BR/>23 (foot adj lift$).mp.<BR/>24 (cast or casts or casting).mp.<BR/>25 (aircast$ or scotchcast$ or neofract).mp.<BR/>26 or/1-25<BR/>27 exp Diabetic Foot/<BR/>28 exp Foot Ulcer/<BR/>29 (diabet$ adj3 ulcer$).mp.<BR/>30 (diabet$ adj3 (foot or feet)).mp.<BR/>31 or/27-30<BR/>32 26 and 31</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2010-03-24 09:46:03 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2009-09-15 13:58:48 +0100" MODIFIED_BY="[Empty name]">Ovid EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-09-15 14:20:25 +0100" MODIFIED_BY="[Empty name]">
<P>1 pressure relie$.ti,ab. <BR/>2 pressure reduc$.ti,ab. <BR/>3 (pressure adj (distribut$ or redistribut$)).ti,ab. <BR/>4 (alternat$ adj pressure).ti,ab. <BR/>5 constant pressure.ti,ab. <BR/>6 exp Bed Rest/ <BR/>7 bed rest.ti,ab. <BR/>8 exp Callus/ <BR/>9 callus.ti,ab. <BR/>10 hosiery.ti,ab. <BR/>11 stocking$.ti,ab. <BR/>12 exp Shoe/ <BR/>13 (shoe$ or boot$ or footwear).ti,ab. <BR/>14 exp Orthotics/ <BR/>15 (orthoses or orthosis or orthotic$).ti,ab. <BR/>16 insole$.ti,ab. <BR/>17 foot insert$.ti,ab. <BR/>18 cushion$.ti,ab. <BR/>19 (heel adj elevat$).ti,ab. <BR/>20 (elevat$ adj device$).ti,ab. <BR/>21 (foot adj elevat$).ti,ab. <BR/>22 (foot adj lift$).ti,ab. <BR/>23 (cast or casts or casting).ti,ab. <BR/>24 (aircast$ or scotchcast$ or neofract).ti,ab. <BR/>25 or/1-24 <BR/>26 exp Diabetic Foot/ <BR/>27 exp Foot Ulcer/ <BR/>28 (diabet$ adj3 ulcer$).ti,ab. <BR/>29 (diabet$ adj3 (foot or feet)).ti,ab. <BR/>30 or/26-29 <BR/>31 25 and 30</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2012-10-24 10:32:20 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2009-09-15 13:59:02 +0100" MODIFIED_BY="[Empty name]">EBSCO CINAHL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-09-15 14:15:02 +0100" MODIFIED_BY="[Empty name]">
<P>S40 S34 and S39<BR/>S39 S35 or S36 or S37 or S38<BR/>S38 TI ( diabet* N3 foot OR diabet* N3 feet ) or AB ( diabet* N3 foot OR diabet* N3 feet )<BR/>S37 TI diabet* N3 ulcer* or AB diabet* N3 ulcer*<BR/>S36 (MH "Foot Ulcer+")<BR/>S35 (MH "Diabetic Foot")<BR/>S34 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33<BR/>S33 TI trough* or AB trough*<BR/>S32 TI ( heel* N2 lift* or heel* N2 float* or heel* N2 splint* or heel* N2 glove* or heel* N2 suspension or heel* N2 elevat* ) or AB ( heel* N2 lift* or heel* N2 float* or heel* N2 splint* or heel* N2 glove* or heel* N2 suspension or heel* N2 elevat* )<BR/>S31 TI heel* N2 device* or AB heel* N2 device*<BR/>S30 TI heel* N2 protect* or AB heel* N2 protect*<BR/>S29 TI heel* N2 pressure* or AB heel* N2 pressure*<BR/>S28 TI ( foot N2 device* or feet N2 device* ) or AB ( foot N2 device* or feet N2 device* )<BR/>S27 TI ( foot N2 protect* or feet N2 protect* ) or AB ( foot N2 protect* or feet N2 protect* )<BR/>S26 TI ( foot N2 pressure* or feet N2 pressure* ) or AB ( foot N2 pressure* or feet N2 pressure* )<BR/>S25 TI ( contact cast* or walk* cast* ) or AB ( contact cast* or walk* cast* )<BR/>S24 TI ( aircast or scotchcast ) or AB ( aircast or scotchcast )<BR/>S23 TI ( orthos* or insole* ) or AB ( orthos* or insole* )<BR/>S22 TI ( orthotic device or orthotic therap* ) or AB ( orthotic device or orthotic therap* )<BR/>S21 (MH "Orthoses+")<BR/>S20 TI ( footwear or foot wear ) or AB ( footwear or foot wear )<BR/>S19 TI ( shoe* or boot* ) or AB ( shoe* or boot* )<BR/>S18 (MH "Shoes")<BR/>S17 TI elevat* N2 device* or AB elevat* N2 device*<BR/>S16 TI static air or AB static air<BR/>S15 TI air bag* or AB air bag*<BR/>S14 TI foot waffle or AB foot waffle<BR/>S13 TI ( sheepskin* or sheep skin* ) or AB ( sheepskin* or sheep skin* )<BR/>S12 TI ( air suspension or water suspension ) or AB ( air suspension or water suspension )<BR/>S11 TI ( constant N1 pressure* or alternat* N1 pressure* ) or AB ( constant N1 pressure* or alternat* N1 pressure* )<BR/>S10 TI low pressure support or AB low pressure support<BR/>S9 TI pressure redistribution or AB pressure redistribution<BR/>S8 TI pressure device* or AB pressure device*<BR/>S7 TI pressure relie* or AB pressure relie*<BR/>S6 TI ( gel or gels ) or AB ( gel or gels )<BR/>S5 TI ( pad or pads or padding ) or AB ( pad or pads or padding )<BR/>S4 TI ( foam* or cutfoam or overlay* ) or AB ( foam* or cutfoam or overlay* )<BR/>S3 TI ( mattress* or cushion* or pillow* ) or AB ( mattress* or cushion* or pillow* )<BR/>S2 TI ( bed or beds ) or AB ( bed or beds )<BR/>S1 (MH "Beds and Mattresses+")</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2012-10-24 10:34:41 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2009-07-22 09:04:30 +0100" MODIFIED_BY="[Empty name]">Risk of Bias definitions</TITLE>
<APPENDIX_BODY MODIFIED="2012-10-24 10:34:41 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Criteria for judgments for the sources of bias</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1.  Was the allocation sequence randomly generated?</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">low risk of bias</HEADING>
<P>The investigators describe a random component in the sequence generation process such as: referring to a random number table; using a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">high risk of bias</HEADING>
<P>The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Unclear</HEADING>
<P>Insufficient information about the sequence generation process to permit judgement of &#8216;Yes&#8217; or &#8216;No&#8217;.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.  Was the treatment allocation adequately concealed?</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">low risk of bias</HEADING>
<P>Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation); sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">high risk of bias</HEADING>
<P>Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non­opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Unclear</HEADING>
<P>Insufficient information to permit judgement of &#8216;Yes&#8217; or &#8216;No&#8217;. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.  Blinding was knowledge of the allocated interventions adequately prevented during the study?</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">low risk of bias</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.</LI>
<LI>Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.</LI>
<LI>Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others unlikely to introduce bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">high risk of bias</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.</LI>
<LI>Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.</LI>
<LI>Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Unclear</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>Insufficient information to permit judgement of &#8216;Yes&#8217; or &#8216;No&#8217;.</LI>
<LI>The study did not address this outcome.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> 4.  Were incomplete outcome data adequately addressed?</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">low risk of bias</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>No missing outcome data.</LI>
<LI>Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).</LI>
<LI>Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.</LI>
<LI>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate.</LI>
<LI>For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size.</LI>
<LI>Missing data have been imputed using appropriate methods.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">high risk of bias</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups.</LI>
<LI>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate.</LI>
<LI>For continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size.</LI>
<LI>&#8216;As-treated&#8217; analysis done with substantial departure of the intervention received from that assigned at randomisation.</LI>
<LI>Potentially inappropriate application of simple imputation.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5"> Unclear</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>Insufficient reporting of attrition/exclusions to permit judgement of &#8216;Yes&#8217; or &#8216;No&#8217; (e.g. number randomized not stated, no reasons for missing data provided).</LI>
<LI>The study did not address this outcome.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.  Are reports of the study free of suggestion of selective outcome reporting?</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">low risk of bias</HEADING>
<P>Any of the following:</P>
<UL>
<LI>The study protocol is available and all of the study&#8217;s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way.</LI>
<LI>The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">high risk of bias</HEADING>
<P>Any one of the following:</P>
<UL>
<LI>Not all of the study&#8217;s pre-specified primary outcomes have been reported.</LI>
<LI>One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified.</LI>
<LI>One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect).</LI>
<LI>One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.</LI>
<LI>The study report fails to include results for a key outcome that would be expected to have been reported for such a study.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Unclear</HEADING>
<P>Insufficient information to permit judgement of &#8216;Yes&#8217; or &#8216;No&#8217;. It is likely that the majority of studies will fall into this category.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> 6.  Other sources of potential bias:</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">low risk of bias</HEADING>
<P>The study appears to be free of other sources of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">high risk of bias</HEADING>
<P>There is at least one important risk of bias. For example, the study:</P>
<UL>
<LI>Had a potential source of bias related to the specific study design used; or</LI>
<LI>stopped early due to some data-dependent process (including a formal-stopping rule); or</LI>
<LI>had extreme baseline imbalance; or</LI>
<LI>has been claimed to have been fraudulent; or</LI>
<LI>had some other problem.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Unclear</HEADING>
<P>There may be a risk of bias, but there is either:</P>
<UL>
<LI>Insufficient information to assess whether an important risk of bias exists; or</LI>
<LI>insufficient rationale or evidence that an identified problem will introduce bias.</LI>
</UL>
<P> </P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>